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Abstract 
 Salmonella is a foodborne pathogen commonly associated with poultry products; the 
economic burden to the U.S. is estimated to be approximately $693 million (without factoring in 
contaminated eggs). Recently, there has been pressure to withdraw sub-therapeutic levels of 
antibiotics (also known as antibiotic growth promoters; AGP) from poultry due to concern over 
antibiotic-resistant bacteria spreading to the human population. Therefore, various feed additives 
have been researched for their ability in providing protection against harmful pathogens and their 
potential growth promoting effects, both of which were attributes of poultry treated with AGP. 
This thesis consists of a comprehensive literature review that covers prebiotics and similar 
compounds, along with their effects on the microbiome. Additionally, the research described in 
this thesis utilized an in vitro anaerobic mixed culture assay as well as an in vivo feeding trial to 
determine the effects of Original-XPCTM (XPC; a compound similar to a prebiotic) on 
Salmonella survival and cecal microbiota modulation.  The in vitro study resulted in rapid and 
significant reduction (from approximately 1.0 to 2.0 logs) of the survival of Salmonella in the 
XPC treatment by the 24 h plating timepoint at both the 28 and 42 d sampling ages. However, by 
the 48 h plating timepoint at the 42 d sampling age, all the treatments containing cecal contents 
were able to reduce the Salmonella recovered to the same degree. These findings suggest the 
ability of XPC to accelerate the rate at which the cecal microbiota is able to reduce Salmonella 
invasion. Analysis of the cecal microbiota in both the in vivo and in vitro assays revealed no 
significant differences in species diversity and richness among treatments. However, cecal 
microbiota maturity revealed significantly increased species diversity and richness, indicating 
bird age to be critical in the modulation of the cecal microbiota.  
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Introduction 
 Antibiotic resistance among bacteria is an emerging issue within the United States that 
has been attributed to indiscriminate usage of antibiotics. As a result, antibiotic growth 
promoters (AGP) that were once commonly used in the food animal industry for improved 
growth performance and prevention of pathogen infection are now being prohibited from use to 
ensure a pure food supply (HHS, 2015). This retraction of AGP has proven to be a challenge for 
poultry producers in keeping their flocks free from infection, while maintaining the growth rates 
that were observed with the supplementation of AGP. Salmonella is one such pathogen 
commonly contaminating poultry. Therefore poultry producers and scientists support and 
conduct research to find and improve treatments that reduce and eliminate Salmonella observed 
in the poultry gastrointestinal tract (GIT). One treatment option is a product that modulates the 
intestinal microbiome of the host, allowing the GIT to be lined with a complex system of 
commensal bacteria: 1) stimulating pathogens to compete for space along the epithelial lining 
(Gabriel et al., 2006; Lawley and Walker, 2012), and 2) generating an unfavorable environment 
for pathogens, in turn prohibiting pathogen survival (Fooks and Gibson, 2002). This thesis 
begins with a comprehensive literature review (chapter one) that begins by describing the avian 
GIT and the GIT microbiome metabolic activities. The term “prebiotic-like compounds” is 
defined within this review for products that are similar to prebiotics and used in adjusting the 
GIT microbiome to maintain poultry health. The review concludes with a description of yeasts 
and their fermentation products, which act as a specific type of prebiotic-like compounds that are 
currently studied for their effects on poultry health. The remaining two chapters utilized a 
compound called Original-XPCTM (XPC), consisting of a proprietary mixture of metabolites 
generated from the fermentation of Saccharomyces cerevisiae. This product and products similar 
  2 
in nature have previously been reported to decrease Salmonella prevalence when supplemented 
to poultry diets, yet little is understood about its mechanism (Gao et al., 2008, 2009; Jensen et 
al., 2008; Osweiler et al., 2010). The second chapter of this thesis details a study using an 
anaerobic in vitro mixed culture assay applied to observe 1) the reduction of Salmonella survival 
and 2) the modulation of the microbiome while the cecal contents are supplemented with XPC. 
The third chapter uses a large-scale in vivo feeding trial to observe the effects that treatment with 
XPC has on the intestinal microbiome. This chapter allowed for the comparison of the less 
descriptive, yet rapid characterization method of a PCR- based denaturing gradient gel 
electrophoresis (DGGE) with the expressive and increasingly cost efficient method of next 
generation sequencing (NGS). Among the two chapters, it is important to note the credibility of 
the results from the in vitro assay as the comparison of those results to the in vivo feeding trial 
were revealed to be in agreement with one another.  
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Abstract 
The poultry industry has been searching for a replacement for antibiotic growth 
promoters in poultry feed as public concerns over the use of antibiotics and the appearance of 
antibiotic resistance has become more intense. An ideal replacement would be feed amendments 
that could eliminate pathogens and disease while retaining economic value via improvements on 
body weight and feed conversion ratios. Establishing a healthy gut microbiota can have a 
positive impact on growth and development of both body weight and the immune system of 
poultry while reducing pathogen invasion and disease. The addition of prebiotics to poultry feed 
represents one such recognized way to establish a healthy gut microbiota. Prebiotics are feed 
additives, mainly in the form of specific types of carbohydrates that are indigestible to the host 
while serving as substrates to select beneficial bacteria and altering the gut microbiota. 
Beneficial bacteria in the ceca easily ferment commonly studied prebiotics, producing short-
chain fatty acids, while pathogenic bacteria and the host are unable to digest their molecular 
bonds. Prebiotic-like substances are less commonly studied, but show promise in their effects on 
the prevention of pathogen colonization, improvements on the immune system, and host growth. 
Inclusion of yeast and yeast derivatives as probiotic and prebiotic-like substances, respectively, 
in animal feed has demonstrated positive associations with growth performance and modification 
of gut morphology. This review will aim to link together how such prebiotics and prebiotic-like 
substances function to influence the native and beneficial microorganisms that result in a diverse 
and well-developed gut microbiota. 
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Introduction 
Poultry production in the past century has transitioned from predominantly breeding 
layers to breeding a mixture of both layers and broilers, based on the evolution of consumer 
demand (1–3). Success in the optimization of different broiler lines is due to genetics as well as 
optimizing diets with more precise nutritional formulations (4, 5). Comparison of individual 
genetic lines has revealed differing intestinal development, feed intake, and digestibility traits 
among other characteristics, which may impact performance (6–9). Improved diets have allowed 
broilers to reach their optimum body weight and feed conversion rate while minimizing 
mortality. Comparing poultry diets from the 1950s to those of the 1990s and 2000s illustrates the 
progress made (10, 11). For example, broiler chickens raised on a typical diet in 1957 had an 
average weight of 1,430 g at 84 days of age, whereas broilers fed a diet from 2001 yielded an 
average weight of 5,520 g at the same age. The feed conversion ratio in 2001 (2.68) was also 
considerably better compared to 1957 (3.26) (11). The current poultry diet contains the 
appropriate balance of amino acids, fatty acids, major and trace minerals, energy, and protein 
necessary for optimum growth (12). 
Supplementation of various biologics have been attempted to enhance poultry feed for 
maximum growth development and health. Antibiotics enhance growth and reduce pathogens 
and although the exact mechanisms remain unclear, numerous working hypotheses have been 
offered (13–17). Antibiotic incorporation into poultry feed has since been tightly restricted 
and/or omitted due to microbial antibiotic resistance, presumably originating from both poultry 
(among other livestock) and humans (18–20). Since the exclusion of antibiotics in diets, a 
number of alternative supplements have been tried (Table 1.1), including prebiotics (21). 
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A prebiotic, as defined by Gibson and Roberfroid (35), is “a non-digestible food 
ingredient that beneficially affects the host by selectively stimulating the growth and/or activity 
of one or a limited number of bacteria in the colon and thus improves health.” This definition has 
been subsequently refined to include the requirements for resistance to the acidic gastric 
environment, gastric enzymes, gastrointestinal absorption, and fermentation by the 
gastrointestinal microbiota while stimulating growth of beneficial intestinal bacteria (22). Being 
indigestible by the upper gastrointestinal tract (GIT) enables it to enter the lower GIT as a 
substrate for health-promoting bacteria, such as bifidobacteria and lactobacilli, thereby 
modulating the microbiota (35). Many feed additives currently used do not fit wholly into the 
strict prebiotic classification; they may lack one or more of the criteria set by Roberfroid (22). 
Although these substances have differing modes of action compared to prebiotics, they have a 
similar end result of a healthy and mature GIT microbiome. They may inhibit pathogenic 
invasion, reduce pathogens in the environment, modulate the host immune response, or enhance 
the host GIT morphology to enable the host to better limit pathogens in the GIT lumen. These 
substances will be referred to as prebiotic-like substances for the remainder of this review. 
The objective of this review is to provide an overview of the effects of prebiotic-like 
substances, particularly those that are yeast-derived, while assessing the influence on microbial 
diversity of the poultry gut microbiota when using single or complex mixtures. In order to 
achieve this, both the gut microbiota as well as prebiotics is reviewed. Additionally, the 
characteristics of complex mixtures of prebiotic-like substances are assessed, including their 
effects on the gut development and physiology, the interactions that occur between host and 
microorganisms, and the potential use of prebiotic-like substances in creating a more healthy gut 
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microbiota. This review includes findings from not only poultry but also human and animal 
models, which may provide insight into potential effects in poultry. 
Gut Microbiome: Terminology and Definitions 
The microbiota is defined as the diverse population of microorganisms in a given 
environment, while the microbiome can be defined by either its genetic or ecological capacities 
(36). Genetic diversity is the entire collection of genes of the microorganisms in an environment, 
while the ecological diversity is all the microorganisms that make up an ecosystem (36). The 
term “microflora,” once commonly used, is now often replaced by “microbiota” to avoid the 
plant connotation from the suffix “flora.” (36). Regardless of the term used, it is essential to use a 
modifying adjective when referring to a specific anatomical region. For example, “gut 
microbiome” is indicating only the microorganisms in the GIT. There are numerous microbiome 
sites in addition to the gut microbiome, as they can be any shared anatomical sites between a 
community of microorganisms (commensal, pathogenic, or symbiotic) (37–39). An oral 
microbiome, for example, is the community of microorganisms that interact with and live within 
the oral cavity. It has several distinct microbial habitats within the oral cavity (gingival, tongue, 
and teeth) and extensions of the oral cavity (esophagus, middle ear, and nasal passages). Each 
different habitat within the oral cavity has its own distinct bacterial population in the form of 
complex biofilms (40). Research has shown that even the distinctive sites of the tongue – the 
dorsal and the lateral regions – possess differing bacterial profiles (41). Other frequently studied 
sites of microbiomes are the skin and the respiratory tract (42–44). The various regions and 
diversity among bacterial communities of the microbiota are indicative of the inherent 
complexity of microbiome research. 
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The gut microbiome is a widely studied topic because of its impact on health as well as 
its characteristic intricacy. The gut microbiome is home to one of the densest bacterial 
populations on earth, with numbers ranging from 108 to 1014/g of digesta (45, 46). The 
microbiome encompasses biochemical and metabolic pathways not found in the host genome; 
this attests to the extent to which the microbiome has evolved (47). Microorganisms that 
comprise the gut microbiota have been found to directly impact the health of the host, providing 
protection against epithelial damage, aiding in digestion, and promoting development of a 
healthy immune system (48, 49). Commensal bacteria, in the GIT of animals, aid in absorption 
of nutrients as well as enhance nutrient utilization (50). Additionally, research conducted thus far 
has shown that earlier development of a mature and diversified microbiota leads to better growth 
of the host and fewer health issues, such as obesity, allergies, and asthma (51, 52). This is in part 
due to healthy competition among microorganisms. 
Avian Gut Anatomy, Structure, and Functionality 
For a thorough understanding of the microbial communities that inhabit the GIT of 
poultry and the effects they may have, a brief description of the poultry GI system is warranted. 
The GIT of poultry, chickens specifically, begins at the esophagus and continues down past the 
crop, proventriculus, and gizzard, through the intestines (duodenum, jejunum, ileum, and ceca), 
and ends at the colon and cloaca (53, 54). The gut microbiota generally refers to the intestinal 
regions and the studies included in this review focus on the duodenum, jejunum, ileum, ceca, and 
fecal contents as well as the structural characteristics to illustrate the gut microbiome of poultry. 
The ceca and their contents are most often studied based on their slow passage rate 
[comparatively, gut transit time from mouth to the lower ileum is approximately 3 h, while 
contents may be retained in the ceca as long as 35 h (55–57)] as it exhibits the most 
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diversification in the bacterial communities it harbors, in turn, indicating its impact on host 
health (54). 
The intestines are multi-layered tubes, containing epithelial, muscular, and mucosal 
layers (58). Each section of the intestine, from the most proximal duodenum passing through the 
jejunum and out to the most distal ileum, contains numerous folds and is lined with villi and 
crypts. The villi are finger-like projections on the surface of the mucosal lining responsible for 
increasing surface area to maximize nutrient absorption and containing a meshwork of capillaries 
to allow nutrients entry into the bloodstream (59). When moving in the distal direction from the 
duodenum down toward the ileum, the mucosal lining reduces in thickness. The villi length and 
crypt depth also decrease in a continual gradation, which supports the notion of the majority of 
nutrient absorption occurring in the small intestine (58). Reduced intestinal weight is associated 
with improved nutrient absorption (60). Microscopic analysis has revealed that the reduction of 
intestinal weight is due to thinning of the epithelial lining rather than to the reduction in intestinal 
length, which is suggested to allow for improved nutrient absorption (61, 62). 
The pancreas functions in hydrolysis of macromolecules, releasing digestive enzymes 
into the duodenum responsible for the hydrolysis of proteins, carbohydrates, and lipids supplied 
by the diet. In addition to enzyme production, the pancreas also produces hormones and 
bicarbonate that aid in metabolism regulation and buffer the intestinal pH, respectively (59, 63). 
The addition of enzymes to the duodenum allows for the small intestine to be the primary site of 
nutrient digestion and absorption. Having a general understanding of the digestive system of 
poultry allows for a more thorough insight into how microorganisms may impact GIT 
physiology. Turk (58) provides a more encompassing review of the entire avian GIT. 
Avian Gut Microbiome Characterization 
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Characterization of microbial communities native to the poultry GIT began in 1901 and 
has since revealed these communities to be both diverse and dynamic (64). As biased culture-
based methods advanced to molecular and sequencing techniques, a broader, more 
comprehensive representation of the microbiome has been recognized (64, 65). Researchers have 
attempted to determine a bacteriological profile of the poultry GIT via 16S rRNA gene-based 
studies; the findings have demonstrated that the majority of the 16S rRNA sequences in the cecal 
contents are not-yet-identified bacterial species (64, 66, 67). These discoveries uncovered the 
shortcomings of previously employed culture-based methods. For example, comparison of 
results obtained from Zhu et al. (64) and Rada et al. (68) found differing levels of Bifidobacteria-
species present in untreated chicken cecal contents. Zhu et al. (64) used temporal temperature 
gradient gel electrophoresis followed by sequencing of the 16S rRNA fragments, while Rada et 
al. (68) used selective media; the experimental designs of both were comparable. The works of 
Zhu et al. (64) and Rada et al. (68) are two such examples for the characterization of the GIT 
microbiome; various techniques have been attempted to ascertain the microbial populations 
present in the different regions of the intestinal tract (Table 1.2). 
Each area of the intestinal tract harbors distinct microbial communities. For example, the 
cecal contents exhibit greater levels of Clostridiaceae-related sequences as opposed to the ileum 
where more abundance of Lactobacillus-related sequences occurs (75). Apajalhti et al. (70) used 
G + C content to demonstrate similar results: the measurement of bacterial communities present 
in the ceca and ileum exhibited considerable variation when comparing the two G + C profiles. 
Variation in microbial communities is not only limited to differing organs, there is also a 
temporal factor in the nature of the microbiome (76). The cecal contents of younger birds 
appeared to possess more transient communities that matured into communities with much 
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greater complexity, while the ileum indicated an overall constant microbiome except at days 3 
and 49 (the youngest and oldest sampling points) (75). The response to newly introduced 
microorganisms also appears to be dependent on sex of the host when analyzed in a mouse 
model; male and female GIT microbiota influence the metabolic activities and immune system 
differently (77). The concept of host factors affecting microbial diversity offers the opportunity 
to use established and healthy microbiomes to generate a working GIT microbial profile. 
However, this may prove to be quite challenging as it has been found that chickens interacting 
together in the same conditions, receiving the same feed, and of the same age and sex still 
display uniquely dominant bacterial communities (78). Although the exact quantities and 
qualities of a healthy microbiota have yet to be determined, a relationship appears to exist 
between the establishment of a mature intestinal microbiome and positive impacts on the host, 
resulting in improved growth and health (79). 
Avian Gut Microbiome: Metabolic Activities 
The poultry GIT is essentially coated in a dense layer of commensal bacteria in a diverse 
array of niches. Generally, the most complex microbial communities are found in the crop and 
the ceca. There is less colonization in the intestines based on the unfavorable environment. For 
example, the duodenum contains numerous enzymes, high concentrations of antimicrobial 
compounds, such as bile salts, and also has a rapidly changing environment due to reflux from 
the jejunum up to the gizzard (80). Traveling further down the GIT, the ileum and ceca become 
more favorable environments with fewer enzymes and antimicrobial compounds; this is reflected 
in the increased concentrations of commensal bacteria, around 109 and 1011 bacteria/g, 
respectively (46). The unique anatomical structure of the cecum allows for the occupancy of 
fermentable substrates not widely available in different areas of the GIT; this enables differing 
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microorganisms to reside and produce large amounts of energy metabolites to aid in achieving 
the bird’s energy requirements (81). 
Research profiling whole body energy consumption patterns has attributed 22.8% to 
being utilized by the GIT and liver (82), but not all of that energy is actually being used by and 
for the host. It was reported that the presence of GIT microbiota significantly increased the 
dietary metabolizable energy in the broiler chicken host, indicating that the microbiota are 
responsible for utilizing the additional dietary energy (83). The commensal bacterial 
communities utilize nutrients from the host’s diet as energy sources, making those nutrients 
unavailable to the host. However, they are able to produce short-chain fatty acids (SCFAs) from 
the fermentation of those nutrients (84). Research suggests the GIT microbiota aid in digestion 
and energy release from starch and fibrous contents, especially in the ceca. It is proposed that the 
amounts and types of SCFAs that are generated in the ceca are in proportion to differing starches 
that enter the ceca (85). Although SCFAs serve as additional energy sources for the host, it is 
suggested that only a proportion (up to 25%) of the overall SCFA energy is recovered by the bird 
(85, 86). In high-fiber and low-energy diets, bacterial digestion of the fiber also releases energy 
in the form of SCFA (84, 87). Along with generating accessible energy, the gut microbiome is 
associated with conservation of energy when nutrient sources (proteins, fats, and sugars) are low 
(88, 89). The production and absorption of SCFAs in the intestine are occurring continuously, 
with more or less being produced due to alterations in the diet or cecal microbiome (85). 
Conversely, the resident microbiome has also been associated with unfavorable effects to 
the host’s utilization of dietary energy. Although the presence of the GIT microbiota has 
indicated a significant increase in levels of metabolizable energy in conventionally raised broiler 
chickens when compared to germfree (89), the metabolizable energy is attributed to the products 
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generated by the GIT microbiota. The variation can be associated with the digestibility of those 
energy sources (dietary fiber and starches) being broken down into monosaccharides and SCFA. 
The SCFA are portrayed as possessing a high metabolic energy value, yet they are inefficiently 
utilized by the host. Therefore the levels of SCFA present are not reflective of the net deposition 
of energy to the host (86, 89). Another potential explanation may be that the presence of the gut 
microbiota increases the cost of energy by altering the rate of energy-consuming reactions 
(89, 90). For example, pathogens attach to the epithelial lining, alter its integrity and function, 
and in turn stimulate the renewal of epithelial lining, which increases the amount of dietary 
energy spent on gut maintenance (27, 91). It has also been observed that conventionally raised 
birds have higher energy requirements for maintenance when compared to germfree birds (92). 
This may be due to the addition of the host’s microbiota usage of metabolizable energy, or the 
host’s microbiota making dietary energy unavailable to the host (92). 
Avian Microbiome and Foodborne Pathogens 
The complex lining of the lower intestines with bacteria serves as a barrier against 
colonization of pathogenic bacteria, which if allowed to occur, could lead to infection. The 
bacteria that settle first in the lining of the intestines necessitate that any other microorganisms in 
search of new residence must compete for space and nutrients in order to survive and colonize 
(80, 93, 94). Establishing the early foundation of a mature GIT microbiota has been associated 
with prevention of infection with pathogens, namely Salmonella, by beneficial bacteria 
outcompeting the pathogenic bacteria for space and nutrients (95–98). In nature, chicks are 
hatched in the presence of maternal fecal contents, allowing rapid colonization of members from 
the maternal gut microbiome (25). In an attempt to colonize newly hatched chicks with a mature 
and healthy microbiome that will discourage pathogenic bacteria from colonizing, chicks have 
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been experimentally inoculated with competitive exclusion culture mixtures (97, 99–102). 
Introduction of the competitive exclusion cultures has proven to be effective in protecting young 
chicks from enteric pathogens and several reviews have been written on various aspects of this 
research (103–106). 
As previously mentioned, commensal bacteria produce SCFA, which are recognized as 
having growth-inhibiting effects on enterobacteriaceae (107–109). The presence of the SCFA 
causes a drop in cytoplasmic pH, which is recognized as a contributing factor to the inhibition of 
pathogen growth (110). Although the mechanisms of SCFAs are not well understood, they are 
known to exhibit bactericidal and bacteriostatic properties (30–32, 111). Russell (30) suggested 
that it is not only the result of a drop in pH caused by the SCFA but also the uncoupling reactions 
produced by the translocation of protons by SCFA that contribute to the growth inhibition effects 
seen. In accordance with this notion, Davidson et al. (112) suggested that because the fatty acids 
produced are weak acids, they are effective as antimicrobials in their undissociated forms as they 
are able to easily diffuse through the cytoplasmic membrane of the microorganism. The fatty 
acids dissociate into anions and protons once in the cytoplasm of the microorganism (maintained 
relatively neutral or slightly alkaline), in turn decreasing the pH and causing conformational 
changes of cytoplasmic proteins, enzymes, and nucleic acids. In an attempt to reestablish a 
neutral/slightly alkaline pH, microorganisms utilize ATP-dependent pump systems to transport 
the anions and protons outside of the cell. This is in accordance with findings of Cherrington et 
al. (113), where incubation of Escherichia coli with propionic and formic acids resulted in 
reduced rates of macromolecular synthesis initially, yet it partially regained synthesis rates after 
continued incubation. 
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Anion accumulation is suspected to be another factor in uncoupling reactions that 
attributes to growth inhibition of bacteria in the presence of SCFA. It is suggested that the 
accumulation of acid anions causes an uncoupling effect of the electron transport chain from 
oxidative respiration (via the passage of molecules in their dissociated and undissociated forms, 
transferring protons into the cell to dissipate the proton motive force) as well as a chaotropic 
effect (disrupting hydrogen bonding in water causing macromolecules in solution to lose 
stability) that are accountable for the increased hydrogen ion leakage into the cell. The cell is 
unable to excrete hydrogen ions rapidly enough, making it difficult for the cell to regain its 
neutral/slightly alkaline intracellular pH (30, 110, 114, 115). The intracellular increase in 
hydrogen is unable to counteract the accumulation of acid anions (116). Another inhibitor of 
bacterial growth by SCFA is the disruption of the membrane of a microorganism by means of 
permeabilization or intercalation, allowing for the release of macromolecules and the 
destabilization of the membrane (117, 118). However, there are instances of pathogenic bacteria 
acquiring resistance to SCFAs (32). For example, pre-incubation of Salmonella with high 
concentrations of SCFA at neutral pH resulted in an acid tolerance response and has also been 
demonstrated to be responsible for modulation of virulence gene expression and attachment/ 
invasion of in vitro tissue culture cells (119–122). 
While the production of fatty acids is inhibitory to invading bacteria, studies suggested 
that the fatty acids are inactive against the species that produced them (123). Smulders et al. 
(124) found that acid-producing bacteria are tolerant to acids and in turn, the acidic environments 
that they generate. Therefore, the influences of the SCFAs produced by autochthonous bacteria 
may provide protection against pathogenic bacteria – Salmonella, coliforms, 
and Campylobacter – intent on colonizing in the intestine while leaving commensal bacteria 
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unscathed (125). However, little else has been reported on the effects of the fatty acids on the 
producing species. 
Key Players in the Gut Microbiota 
In the past, the microorganisms colonizing the GIT were thought to be commensal, 
neither beneficial nor harmful to the host, as opposed to being mutualistic (37). However, 
numerous germfree experiments in various animal models have indicated the value of these 
indigenous microorganisms (126–128). There has been overwhelming data collected revealing 
the beneficial impacts on both host physiology as well as immunology (75, 129). Several studies 
have indicated that introducing a balance of beneficial microorganisms to the poultry microbiota 
improves body weight gain and feed conversion ratio as well as warding off common diseases in 
poultry, such as Newcastle disease and infectious bursal disease (130–132). However, in order to 
better promote strategies for increasing the presence of beneficial bacteria, those bacteria and 
their interacting counterparts must be identified. 
Although being incredibly diverse, the most abundant microorganisms in the gut 
microbiota of poultry are primarily anaerobic (54). This is somewhat expected since there is little 
to no oxygen available as an electron acceptor in the lumen, although the concentration of 
oxygen is greater toward the epithelium, thus forcing bacteria to use fermentation to produce 
pockets of organic acids within the lumen (133). Moreover, Sun and O’Riordan (133) suggest 
that as a result of this environment, it is necessary to investigate SCFAs more in depth because 
bulk analysis does not reveal the true nature and spatial arrangement of these acids (which would 
further indicate the location and family of anaerobic bacteria). There is no consistent data 
available indicating the overall Gram status of poultry GIT microbiota. Investigation into the 
commensal bacteria present in an untreated chicken ceca has resulted in an array of bacterial 
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communities (Gram-positive Y-branched, Gram-positive non-sporulating, Gram-negative) and 
may be attributed to the rearing conditions, chicken breed, diet, or even the cultivation and 
enumeration methods applied for bacterial characterization (125). Nevertheless, there are trends 
observed in available data investigating the microbial populations in broiler chickens grown in a 
conventional poultry flock and those raised under laboratory conditions (76, 134). 
Lactobacilli and bifidobacteria are two of the more well-known beneficial bacteria, 
however, there are numerous others: Bacillus, Enterococcus, E. coli, Lactococcus, 
Streptococcus as well as undefined mixed cultures (Table 1.3) (23). These bacteria are 
indigenous to the GIT, occupy space, and consume nutrients along the intestinal tract, limiting 
the colonization of pathogenic bacteria. In addition to competing for space and nutrients, these 
bacteria have been recognized for exporting bacteriocins, which can target and kill invading 
pathogens (133). All of these microorganisms fit under the umbrella term probiotics. Like 
prebiotics, probiotics also have specified criteria and characteristics: (1) non-pathogenic and of 
host origin, (2) resistant to gastric pH and processing/storage, allowing them to persist in the 
intestinal tract, (3) able to adhere to epithelial and mucosal membranes, (4) modulate immune 
responses, and (5) produce inhibitory compounds (23). It is the complexity and broad diversity of 
the beneficial microorganisms that make up the microbiome and allow for a mature and healthy 
host (51, 52). 
Bacteria may be beneficial to the host by aiding in degradation of polysaccharides 
otherwise indigestible to the host. The monosaccharides produced can be subsequently broken 
down further into SCFAs and lactic acid (37). As previously mentioned, both lactobacilli and 
bifidobacteria are beneficial and indigenous to the human and chicken GIT (145). Lactobacilli 
are members of a group collectively referred to as lactic acid bacteria, which metabolize 
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carbohydrates to produce lactic acid as the primary end product (146). Oligosaccharides are their 
main nutritional source, which is reflected in their residence in ecological niches rich in 
carbohydrate-containing substrates, most commonly plant material, spoiled or fermented 
foodstuffs, and mucosal membranes of humans and animals (147). Along with their broad range 
of habitats, lactobacilli are able to adapt to various conditions by altering their strictly 
fermentative metabolism accordingly; they may be obligately homofermentative, facultatively 
homofermentative, or obligately heterofermentative (148). Their fermentative status is based on 
the levels and proportions of end products they generate from fermentation of differing 
substrates (although other factors, such as chemical and physical environment, play a role in 
determining fermentative status). Obligately homofermentative indicates that their primary 
fermentation product is lactic acid (>85%) generated by fermenting hexoses (149). Facultatively 
homofermentative indicates that they are capable of fermenting hexoses and pentoses using 
different pathways to generate lactic acid (although under low substrate concentration and 
strictly anaerobic conditions, they are capable of producing acetic acid, ethanol, and formic 
acid). Obligately heterofermentative lactobacilli ferment hexoses generating equimolar amounts 
of lactic acid, CO2, and acetic acid (148–150). Although the end products produced are a fair 
indication of fermentative status, they are not the sole factor. These microorganisms are 
aerotolerant and acidophilic, allowing for the GIT to be an optimal residence (146, 151). 
Bifidobacteria are another well-documented example of beneficial bacteria. They are 
often associated with lactic acid bacteria for their production of lactic acid, however, they are 
phylogenetically distinct. Bifidobacteria are Gram-positive, heterofermentative, and non-motile 
(152). Like lactobacilli, bifidobacteria digest oligosaccharides to use as carbon and energy 
sources, to produce lactic acid, acetic acid, ethanol, and formic acid (153). They are not 
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exclusive to the utilization of dietary compounds, they can also digest carbohydrates produced by 
other members of the GIT (154). Additionally, they are capable of internalizing simple sugars 
remaining in the environment, thus preventing pathogenic bacteria from utilizing them as a 
nutrient source (155). 
Both lactobacilli and bifidobacteria are known to be members of the intestinal microbiota 
in animals and humans; their presence is important for the maintenance of the GIT microbiota 
(156–158). Being that lactobacilli and bifidobacteria are autochthonous and dominant in the GIT, 
they can be utilized as a control method of pathogenic bacteria by competition, for example 
Clostridium perfringens (156). Lactobacilli and bifidobacteria possess characteristics that allow 
them to out-compete pathogenic bacteria. Various strains of lactobacilli adhere to intestinal 
epithelial-like cells and exhibit antimicrobial activity against bacteria typically found in the 
(human) GIT (157). A link between the lactobacillus strain’s pH tolerance and antimicrobial 
properties has been reported, both in vitro and in vivo (157). 
Different species of lactobacilli and bifidobacteria produce various antimicrobial agents, 
which allow them to be inhibitory toward pathogenic bacteria. Many species of lactobacilli and 
bifidobacteria produce SCFA; the production of these acids causes a drop in intestinal pH. The 
lowered pH level extends the lag phase for sensitive microorganisms (124). The undissociated 
forms of these acids are able to penetrate the microbial cell and hinder metabolic functions 
(further information on the mechanisms of these acids was discussed in a previous section of the 
current review). Another end product generated from lactobacilli and bifidobacteria is CO2, 
which has demonstrated inhibition of microbial growth (149). The inhibitory mechanism of 
CO2 is unclear, although Eklund (159) was able to rule out the proposed mechanism of 
CO2 accumulation in the membrane of the microorganisms, physically interrupting the bacterial 
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membrane. Growth of E. coli, Bacillus subtilis, Pseudomonas aeruginosa, and Bacillus 
cereus has been shown to be inhibited in the presence of CO2 at various concentrations (159). 
Succinic acid is produced by both lactobacilli and bifidobacteria, although at minimal levels 
(160, 161), and is associated with antibacterial activities in a multitude of environments 
(162, 163). Diacetyl is an end product of lactobacilli that exhibits antimicrobial effects. It is 
suggested that diacetyl is more effective in a lower pH (≤7) causing it to be lethal to Gram-
negative bacteria and inhibitory of yeasts (164). Bacteriocins, produced by lactobacilli, may have 
a narrow or broad range of activity. Lindegren and Dobrogosz (149) have reviewed the various 
antimicrobial agents produced by lactic acid bacteria in more detail. 
Overgrowth of any single type of bacteria can have unfavorable effects on the host. 
Lactobacilli are considered beneficial bacteria, however, antibiotic growth promoters that 
stimulate improved growth of broilers were also associated with heightened sensitivity of 
lactobacilli to those antibiotics (165). Although the host may benefit from the commensal 
bacteria competing with pathogenic bacteria, an overgrowth of commensal bacteria can be 
detrimental to the host by excessive uptake of nutrients making them unavailable to the host 
(166). Additionally, overgrowth of lactobacilli can impair host fat absorption by not allowing 
proper biotransformation – deconjugation and dehydroxylation – of bile acids (14). Overgrowth 
of bacteria can also lead to overproduction of fermentation end products to the detriment of the 
host. For example, overgrowth of Streptococcus bovis, a commensal lactic acid-producing 
bacteria can generate considerable acid production and a concomitant lowering of the 
surrounding environment pH. This sequence can be advantageous for competing against 
pathogens. Consequently, under in vitro incubation conditions in co-culture with Salmonella 
typhirmurium growth of S. bovis can behave as a probiotic and directly limit Salmonella growth 
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as a function of carbon source and time of inoculation (144). However, when easily fermented 
carbohydrates are fed to ruminants, excessive S. bovis growth can occur in the rumen resulting in 
rapid lactic acid overproduction, subsequent lowering of the ruminal pH, and the eventual 
development of a harmful ruminal lactic acidosis condition in the animal (167). Therefore, even 
though S. bovis might be considered a gut commensal organism, and in some cases a probiotic 
candidate, it can also be associated with host clinical disease states, such as bacterial endocarditis 
and colon cancer in humans (144). 
Introduction and History of Prebiotics 
The most widely accepted definition of prebiotics are non-digestible feed ingredients that 
are selectively fermented by beneficial bacteria in the lower GIT (capable of withstanding harsh 
conditions in the upper GIT) so as to provide energy to promote bacterial growth and metabolism 
in the colon which contributes to specific changes that lead to improved host health 
(22, 35, 168). Colonic food is a non-digestible ingredient that makes it past the upper GIT and 
into the colon, serving as a substrate for non-specific bacterial inhabitants, both beneficial and 
harmful (169, 170). Not all colonic foods are necessarily prebiotics; the rationale for designating 
a compound as a prebiotic or not depends upon whether beneficial bacteria alone are able to 
digest it. Some miscellaneous compounds that serve as colonic food, but do not fall into the 
category of prebiotics because of the non-specific targeting of microbiome bacteria include 
resistant starch, non-starch polysaccharides, non-digestible oligosaccharides, and yeast 
fermentation products (171). There have been numerous studies conducted and reviews written 
covering common prebiotics and their beneficial impacts; therefore they will not be discussed in 
detail here (Table 1.4) (35, 172–174). 
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Some lesser-studied prebiotic-like compounds are Saccharomyces 
cerevisiae fermentation products (SCFPs) or yeast culture (YC) components; these compounds 
do not fall into the precise definition of prebiotics as set by Roberfroid (22), among other 
classical definitions. However, they have prebiotic-like effects in that they have been shown to 
enhance nutrient utilization and digestibility, as well as improving the immune system and 
inhibiting pathogen-intestinal cell interaction by modifying the GIT microbiome (179–181). The 
fermentation of S. cerevisiae –undefined strains – produces SCFP. They include the fermentation 
products and metabolites, the media used in the fermentation to preserve fermentation activity, 
and both the yeast cell wall fragments and residual live yeast cells; thus, they share 
characteristics in both probiotic and prebiotic realms (179). There are commercial YC products 
available that are being more thoroughly investigated to identify their exact effects and maximize 
the directed influence(s) they may have. 
Because yeasts are most often associated with the wine making, brewing, baking, and 
other fermenting industries, it is critical to consider why these unique organisms were initially 
promoted for use in improvements of animal and human health. In order to do this, a brief review 
of the history of yeast that led to its usage as a feed additive is discussed in the following section. 
Introduction to Yeast: History and Background 
To understand the current use of yeast and yeast products in food and agricultural 
settings, it is important to at least briefly describe the history of yeast in scientific applications 
and the evidence for the close relationship among yeast strains originally uncovered and those 
used in today’s laboratory-based research. Humans began using yeast over 7,000 years ago, with 
its earliest usage dating back to the Neolithic times for wine making (182, 183). In the past 
century, yeasts have been investigated on a genetic level after the Carlsberg Laboratory 
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introduced scientific concepts to the brewing industry, as discussed by Greig and Leu (184). In 
the 1930s, the genetic analysis of yeast became accepted based on its potential as an 
experimental organism; it was pioneered by Øjvind Winge and Carl Lindegren (185). Winge 
used a strain isolated from the Carlsberg Laboratory, while Lindegren used a strain, EM93, 
isolated from rotting Californian figs (182). Yeast continued gaining popularity in the scientific 
field for its ease in gene manipulation (182). In the 1950s, Robert Mortimer constructed the 
strain S288C, which has been purported to share more than 85% of its genome with EM93, 
Lindegren’s original strain (most laboratories involved in the analysis of yeast use a derivative of 
EM93 – a strain of S. cerevisiae). This strain was subsequently sequenced in 1996, making it the 
first fully sequenced yeast genome (186, 187). For further purposes of the current review, S. 
cerevisiae is the main species of yeast discussed unless otherwise indicated. 
Yeast in the Laboratory 
A renowned model organism, yeast is a single-celled fungal eukaryote that most often 
divides by budding. Yeasts are used in various industries because of their ability to ferment 
sugars in the absence of oxygen to produce CO2 and alcohol. In a laboratory setting, yeasts are 
most often used for analysis as a model template to study higher eukaryotic organisms. Yeasts 
are ideal for studying processes known to occur in more complex eukaryotic organisms because 
even though yeasts are unicellular, they encode similar proteins and are thus representative of 
more complex organisms at the cellular level (188). When comparing all yeast protein sequences 
to mammalian sequences, of the potential protein encoding regions in yeast, “statistically robust” 
homology among the two was observed (189). Because of the lack of mammalian protein 
families and proteins sequenced, there may be much greater similarities between the two. 
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Part of the attraction of yeast as an experimental model is the ability to easily manipulate 
and mutate genes, either on plasmids or in the yeast chromosome itself, to view the resulting 
phenotypic effects (182). An insight into its fairly simple manipulation is evident in research 
performed by both Caspeta et al. (190) and Liu et al. (191). Caspeta et al. (190) manipulated S. 
cerevisiae into expressing thermotolerance to temperatures ≥34°C (typical response to these 
temperatures is serious impairment of function) by exposing the isolate for short stretches of time 
to increased heat followed by serial batch transfers. This resulted in non-inheritable heat tolerant 
strains that exhibited increased growth rates as well as increased glucose consumption rates at 
higher temperatures when compared to thermolabile strains (190). Thermotolerance has also 
been bestowed upon S. cerevisiae by the introduction of genes from organisms that are naturally 
thermotolerant. This transfer of genes allows for inheritable alteration in future generations of S. 
cerevisiae. Duina et al. (182) illustrated the extent to which yeast has proven its efficacy as a 
model organism, discussing research advancements and accolades (Nobel Prize and Lasker 
Award) in an array of fields achieved by utilizing yeast. 
Although great progress has resulted from the study of yeast, it has also stimulated 
further inquiry. Yeast researchers began with the goal of determining functions of single genes 
and proteins, but now seek a “systems level” approach. The benefit of understanding how 
proteins interact to maintain cellular functions (metabolism, reproduction, growth, regulation, 
signaling, and homeostasis) is now at the forefront for yeast biology (192). Yeast’s position as a 
model organism for various scientific fields is reviewed more thoroughly in several articles and 
therefore will not be further discussed here (192–194). A review by Siddiqui et al. (195) 
encompasses the potential of engineering yeasts to contain secondary metabolite pathways for 
pharmacological purposes. Additionally, Sherman (196) has generated a comprehensive review 
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(both extended and truncated versions available) on the biological basics of yeast, which includes 
a section on a variety of outside literature references for yeast. 
Yeast Metabolism 
Yeasts are capable of cellular respiration in the presence and absence of oxygen; for this 
review, we will discuss respiration only in the absence of oxygen, as it is most applicable to the 
topic of the current review. Anaerobic respiration, or fermentation, is the process of breaking 
down sugars to generate energy for carrying out cellular processes. In anaerobic cellular 
respiration, sugars are broken down into pyruvate and subsequently decarboxylated and reduced 
to form CO2 and ethanol. For fermentation to begin, any complex sugars must be broken down 
into simple sugars (e.g., sucrose to glucose and fructose) via enzymes from yeasts, adding an 
additional step to the fermentation process (197). In the process of understanding this, it is 
recognized that complex carbohydrates (starches and fiber) are more challenging for yeasts to 
ferment than simple sugars. Investigation into the types of sugars and environments yeasts are 
capable of fermenting is necessary to optimize the production and utilization of yeast 
fermentation products. By understanding the conditions in which yeast fermentation is 
optimized, they can be engineered to generate additional metabolites that may prove to be 
beneficial for use in animal feed. 
Yeast as an Animal Feed Additive 
The usage of live yeast and yeast products in animal feed is not a new concept, although 
pinpointing the exact point of its conception has proven to be challenging. It is suggested that the 
introduction of YC in animal feed was not until the 1980s (198). It appears that the majority of 
research has been dedicated toward ruminants, while equine, porcine, poultry, and companion 
animals received attention to a lesser extent. Initially, yeast was used in an array of modes 
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because of the large quantities of yeast biomass waste generated by distilleries (and other yeast 
utilizing industries) (199). It was used as a feed additive because it was a rich source of protein, 
fiber, and minerals. It has been hypothesized that both viable and non-viable yeast cells provide 
essential B vitamins and organic acids (200). In the past, both viable and non-viable yeast cells 
have been added to animal feed – including poultry feed – and resulted in increased host growth 
and improved health (199). 
It is essential to have a precise definition for YC, so it is not confused with using live 
yeast (probiotic/direct fed microbial form) or yeast extract (only soluble portion of yeast 
autolysis) products (201). As described in a previous section of the current review, YC contains 
the cellular constituents as well as residual viable cells. It is effective when used because it 
contains lysed yeast cells; this allows for the nutrients within the yeast cells to be available for 
digestion and absorption (202). These yeast cells are lysed by autolysis; they are subjected to 
temperature or osmotic shock, thereby killing the yeast cell while leaving the endogenous 
enzymes undamaged. The yeast cell’s own enzymes begin to degrade the yeast cell, releasing its 
contents and further degrading its proteins into amino acids (203). Some yeast cells that are 
capable of tolerating the temperature or osmotic shock, do not autolyze, and remain 
metabolically active. 
The mode of action of YC is seen to enhance digestive and fermentative functions of the 
GIT, while modifying activities of the GIT microbiota, although the mechanisms are less clear 
(198). Based on in vitro and in vivo studies, supplemented YCs appear to have several impacts 
on the rumen microbiota including increased numbers of beneficial bacteria and fiber digesting 
bacteria as well as shifting away from hydrogen consuming methanogens and toward bacteria 
capable of converting hydrogen and CO2 to acetic acid, all of which could, in turn, potentially 
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benefit the ruminant host animal either directly or indirectly (204, 205). Enhanced growth 
performance resulting from the supplementation of YC with probiotics (Lactobacillus 
acidophilus and Streptococcus faecium) has indicated its potential effect of increasing digestion 
and absorption of the GIT microbiota occurring in broiler chickens (206). de Oliva Neto et al. 
(207) conducted studies on the antibacterial properties of YC supernatant, which indicated a 
reduction of pathogenic bacterial growth when tested against a common distillery bacterial 
species. Interestingly, the supernatants were tested as both fresh and post freeze/thaw, and 
reported similar results indicating the antimicrobial activity could withstand freezing. 
Conversely, when heat (90°C for 20 min) was applied, the antibacterial activity was destroyed. 
Accordingly, YC and yeast extract have yielded varying results, which suggests the necessity for 
metabolically active yeast cells. When supplementing heat-treated inactive yeast cells to steer 
diets, there was no effect on the concentrations of cellulolytic bacteria, while supplementing live, 
metabolically active yeast cells increased the concentration of cellulolytic bacteria (208). 
In addition to their ability to interfere with bacteria due to their relative large size, 
supplementation with live yeast products has led to a few suggested modes of action (209). One 
mechanism suggested by Jouany et al. (204) involves metabolic competition with bacteria that 
may be adhering to and digesting fiber or starch molecules. In this scenario, the yeasts ferment 
the carbohydrates produced, prohibiting their usage by other bacteria. Another mechanism of 
action of live yeast cells is their ability to produce protective products with antitoxin effects 
(210). Yeast intake has resulted in a stimulation of activity of host intestinal brush border 
enzymes, which has counteractive effects to those of pathogens, along with supplying the host 
with additional enzymes (211). Elimination of oxygen has been deemed the most influential 
mode of action in ruminants (212). Although there is little oxygen present in the GIT, live yeast 
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cells scavenge for excess oxygen introduced by food and water intake; this allows for a more 
optimal environment for anaerobic bacteria (204, 212). Most all implications regarding the 
mechanism of oxygen elimination have been derived from studies conducted on ruminants. 
As noted previously, the majority of the studies on the effects and mechanisms of YC 
have been performed on ruminants. Although such studies may be a good indicator of the 
potential use of YC in other animals, it can also be expected that there will be differences seen 
among ruminants and non-ruminants. For example, considerable research has been conducted on 
the effects of milk production in cattle, while this is beneficial for other lactating animals, the 
information gleaned from these studies holds little merit for poultry researchers. Instead, 
conducting in vitro and in vivo studies on specific animal subjects of interest would be more 
useful in identifying the mechanisms of YC in those animals rather than projecting 
ruminant/rumen microbiota results onto non-ruminant species. 
Impact of YC on Host: Microorganism Interactions 
The effects of YC on the intestinal morphology in swine have indicated increased jejunal 
villi width, which allows for greater digestive and absorptive intestinal capacity leading to better 
body weight gain when compared to controls (180). In contrast, poultry data obtained has thus 
far indicated significant differences in intestinal morphology (213–215). Supplementation of YC 
has resulted in more shallow crypt depths, indicating less necessity for cell renewal and turn-
over, allowing for decreased host energy utilization for intestinal epithelial maintenance (216). 
Feed efficiency and body weight gain have both resulted in significant increases when YC, yeast 
derivatives, and live yeast cells are added to the poultry diet (215, 217, 218). 
Inclusion of YC in animal feed has led to suggestions that they may aid in the clearing of 
pathogens from infected animals. A study involving the inoculation of pigs with Salmonella 
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suggested that the inclusion of YC in the diet allowed for rapid shedding of the pathogen from 
the GIT (180). Supplementation of broiler feed with YC has also been seen to enhance adaptive 
immune system T lymphocytes, allowing for better clearing of the pathogens (181). El-Husseiny 
et al. (219) observed that commercial YC were able to significantly increase antibody production 
against SRBC, much in agreement with the findings of Al-Homidan and Fahmy (220), who 
reported significantly higher antibody titer concentrations in response to Newcastle disease in 
broilers fed YC. 
Further examination into the components of yeasts’ cell walls indicates the beneficial 
structural polysaccharides present and released into culture when yeast cells autolyze. Mannan-
oligosaccharide (MOS) is included in the YC as it is derived from the outer cell wall of S. 
cerevisiae. MOSs bind to pathogenic bacteria in the GIT, preventing their attachment to the 
mannan residues on intestinal epithelia (221). This not only protects the host from pathogens but 
also allows for host energy reserves to be utilized for their own growth rather than to the repair 
and regeneration of the epithelial lining (222). β-glucans are also released when the yeast cell 
wall is degraded; presence of these molecules can lead to pathogen inhibition along with 
immuno-modulating effects. Similar to MOS, β-glucans act by preventing pathogens from 
binding to the villi of the gut mucosa (214, 216). Additionally, β-glucans are known to activate 
phagocytes, natural killer cells and B and T lymphocytes as well as increase cytokine production 
and phagocytic activity of macrophages (223). 
Mannan-oligosaccharide supplementation has been reported to increase broiler growth 
performance when supplemented in their diet (224, 225). In vitro experimentation has indicated 
that addition of MOS inhibits the attachment of enteropathogenic E. coli to the gut mucosa as 
well as removing attached E. coli from the mucosa (226). Inclusion of yeast fermentation 
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products, like MOS, appears to reduce pathogenic bacterial populations. The mechanism is 
unclear, although the agglutination of the pathogens with sugars from the yeast cell wall occurs 
rather than attachment to the host intestinal lining is one hypothesized mechanism (227). Yang et 
al. (228) indicated MOS altered the gut microbiota of broilers and reduced the number of 
mucosal-associated coliforms. 
Although some studies suggest a positive association between yeast and growth 
promotion (229, 230), other studies have indicated no positive effects on inclusion of YC in 
broiler diets (231). Paryad and Mahmoudi (229) indicated that inclusion of 2% yeast 
(Saccharomyces cerevisae) in broiler chicken diets resulted in significant differences in body 
weight gain, feed intake, and feed conversion rate when compared to controls. Similarly, 
investigation into YC on growth promotion in lambs suggested its efficacy, resulting in increased 
feed intake and growth by 8 and 26%, respectively. Conversely, similar research conducted on 
lambs evaluating the efficacy of three yeast strains and a mixed culture resulted in little 
consistency and lacked an overall effect when compared among yeast strains (232). Adebiyi et 
al. (231) also showed no significant differences in body weight gain in broiler chickens when fed 
varying percentages of YC. 
Yeast Metabolites and Metabolism as Prebiotic-Like Substances 
In addition to the structural polysaccharides derived from the yeast cell wall, yeasts 
generate a number of metabolites that may offer benefits to the host animal when supplemented 
to animal feed. Metabolites include carotenoids, vitamins, enzymes, amino acids, and some 
miscellaneous products (200). Several yeast species are naturally capable of producing 
carotenoids (including β-carotenes), which are subsequently metabolized into vitamin A (200). 
Vitamin A aids in cellular differentiation and proliferation, making it critical for intestinal 
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maintenance and health (233). The enzyme responsible for the synthesis of vitamin A from β-
carotene is β,β-carotene 15,15′-monooxygenase, which has been isolated and characterized from 
the intestines of poultry, among other animals (234, 235). Although S. cerevisiae is not capable 
of naturally producing carotenoids, it is capable of and has been engineered to express a 
biosynthetic pathway for the production of β-carotene (236). 
Other vitamins (vitamin precursors) produced by yeasts include ergosterol, L-ascorbic 
acid, and D-erythroascorbic acid. Ergosterol is particularly abundant in S. cerevisiae, accounting 
for up to 90% of the total sterols (237). It is located in the membrane of yeasts and is responsible 
for its fluidity, structure, permeability, and activity of membrane-bound enzymes (238). 
Ergosterol is a precursor to both vitamin D2 and cortisone (239). Vitamin D2 is responsible for 
the proper absorption and transport of calcium, among other minerals (240). D-Erythroascorbic 
acid is also synthesized by S. cerevisiae and depending on the substrates available, that pathway 
can be manipulated into producing L-ascorbic acid (vitamin C) (241). The ingestion of vitamin C 
has been suggested to alleviate some of the repercussions of heat stress: poor immune function 
and growth performance (242). However, instances of supplementation of L-ascorbic acid in 
poultry diets have had varying results; some resulted in increased levels of superoxide dismutase 
in 45-week-old broilers, while others revealed no effect on the activities of antioxidative 
enzymes, superoxide dismutase included in 7-week-old broilers (243, 244). 
Yeasts are recognized for their production of enzymes expressing various activities (245). 
Jones (246) wrote a comprehensive review documenting the activities of the proteolytic systems 
in S. cerevisiae, along with mentioning other enzymes elucidated in S. cerevisiae 
(carboxypeptidases, aminopeptidases, and dipeptidyl aminopeptidases). An enzyme 
in Saccharomyces boulardii, a subtype of S. cerevisiae, was found to degrade the ileal receptors 
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in rats for toxin A generated from Clostridium difficile (a food-associated pathogen causing 
gastroenteritis; one study isolated C. difficile from 2.3% of broiler chickens tested) (247, 248). 
The degradation of the receptors prohibits the toxin from binding and prevents infection from 
occurring (249, 250). There have been multiple other proposed mechanisms of action for yeast 
on the immunoprotective effect in the GIT, specifically the prevention of C. difficile infection: 
(1) S. boulardii releases proteases that hydrolyze toxins and prevent its binding to the intestinal 
receptor (250), (2) S. boulardii is capable of stimulating the activity of disaccharidases in the 
intestinal brush border with no additional alterations of the intestinal mucosa (211), and (3) S. 
boulardii increased the production and secretion of glycoproteins, namely the secretory 
component of immunoglobulin A (251). Potentially, by narrowing the focus on the exact 
mechanism of action, S. cerevisiae could be engineered to confer said mechanism and 
supplemented into animal (poultry) feed to prevent colonization of C. difficile. 
Invertase is another enzyme produced by S. cerevisiae; it hydrolyzes sucrose into glucose 
and fructose (252). Invertase efficiency and sucrose availability allows for glucose to be a carbon 
source for S. cerevisiae (252). Ideally, provided the diet contained appropriate levels of sucrose, 
one could engineer S. cerevisiae to overproduce invertase and subsequently add it to poultry 
feed. This would allow increased production of glucose, available not only for its own needs but 
also for other microorganisms in the surrounding environment. This mode of action would not be 
selective toward beneficial bacteria in the microbiome. 
Yeasts have multiple amino acid transport systems; amino acids are incorporated into 
proteins or they are broken down and utilized as nitrogen and carbon sources to promote growth 
(253). Yeasts and yeast derivatives are capable of producing amino acids; therefore 
supplementation to animal feed would provide both the host and the microbiome with amino 
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acids. Almquist (254) reviewed the essential amino acid requirements in young chicks, laying 
hens, and turkeys; Almquist included a table outlining the percentages of each amino acid to 
reach a specific protein level. Amino acids are necessary for poultry to have proper growth and 
promote efficient weight gain and feed conversion ratios (255). Lysine appears to be one such 
amino acid that plays a significant role in the body composition of poultry (256). Mutants of S. 
cerevisiae have been revealed to produce up to 17 times as much lysine as wildtype; thus this 
rich source of lysine may prove to be valuable to the growth and development of poultry (257). 
Miscellaneous metabolites are also produced in S. cerevisiae, including toxins 
responsible for the “killer phenomenon.” Originally, this phenomenon was considered to be 
lethal only toward members of the same species; however, further investigation has led to the 
recognition of these toxic species to have destructive consequences reaching both prokaryotic 
and eukaryotic organisms (258–261). Polonelli and Morace (261) acknowledge that the 
inhibition of outside species may not be a direct impact on the toxins secreted, but more of a 
concerted effort from multiple metabolites. Nevertheless, these toxic species of S. cerevisiae are 
displaying lethality toward unrelated species. This can be utilized to the advantage of 
commercial poultry production, provided further research is conducted on characterizing whether 
this toxicity also occurs toward beneficial bacteria. 
Conclusions: Impact on Poultry Industry and Future Directions 
In the search for a replacement to antibiotic growth promoters, the poultry broiler 
industry has two main objectives, a substance that (1) increases the growth of broiler chickens 
(body weight gain and feed conversion ratio) and (2) prevents the colonization of invading 
pathogens. Ideally, a single feed additive would prevent pathogen colonization while developing 
beneficial microbiota to aid in bird growth and feed conversion (262). Multiple feed additives 
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have been attempted: antimicrobial agents, probiotics, prebiotics, and prebiotic-like substances. 
Probiotics need to be clearly identified and carefully analyzed to understand the influence they 
may have on the poultry GIT microbiota. As discussed previously, lactobacilli and bifidobacteria 
are two known groups that provide the host health and well-being based on their end products. 
These bacteria both ward off pathogens by creating an unfavorable environment against 
pathogen retention in the gut and also generally aid host GIT health, in turn resulting in enhanced 
bird growth (133). 
To increase the efficacy of supplying probiotics to the host, the concept of synbiotics has 
been suggested. Synbiotics entail equipping the beneficial bacteria with substrates specific to 
their metabolic needs (23). Potentially, this allows for the greatest impact as it reduces the 
substrates taken by the probiotics from the host. Prebiotic-like substances are often times non-
selective, therefore, combining a probiotic and a prebiotic-like substance does not fit into the 
synbiotic definition (263). Understanding the effects and specificity of probiotics, prebiotics, and 
prebiotic-like substances will allow for the best match of known commensal bacterial 
communities and substrates for a given host. 
Yeast cells and YC products developed thus far have been extensively examined for their 
effects as supplements in animal feed. Numerous studies report the positive association with 
growth performance, immunostimulation, and microbiome modulation in animals and humans 
(209). In addition to being explored for their positive impacts as supplements in animal feed, 
yeasts and their derivatives have been investigated for their low risk and assurances of safety in 
their usage. Yeasts are cost efficient in both production and formulation (200). They do not have 
the ability to transfer genes they may acquire to pathogenic or commensal bacteria, or to the host. 
Yeasts are able to resist acquisition of antimicrobial resistance as well as not allowing for the 
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transfer of such resistance (209). This also allows yeast to be safely used in parallel with 
antibacterial agents. Yeasts also have multiple mechanisms of action, allowing them to be 
productive in a range of environments (200). 
A more thorough understanding of the microbiome can elucidate the mechanisms of 
prebiotics and prebiotic-like substances. The GIT microbiome is distinct and unique in its 
functionality relying on the presence of a definable, and potentially identifiable, microbial 
consortia. Understanding the influences of the members of the microbiome and also the 
microbiome as a single entity will allow for a more directed approach in the search of 
therapeutics and growth promoters. The GIT microbiome may be more appropriately considered 
as an additional organ; it has impact on host growth and development, and host health. 
The limitations in previous research conducted have made future research necessary to 
resolve unanswered questions. It is imperative to define universal and standardized detection 
methodology to identify the bacterial communities present in the healthy, mature poultry 
microbiome. This would alleviate the issue of having varying results based on detection methods 
utilized. In addition, evaluating the currently suggested probiotic candidate organisms 
(Table 1.3) indicates the potential advantages of involving multiple potential probiotic bacterial 
and yeast strains to exhibit a concerted effort in maintaining GIT health. This would allow for 
the identification of potentially more uniform mixed probiotic cultures consisting of functionally 
well-defined individual bacterial members that when used to inoculate newly hatched chicks 
ensures more rapid development of a mature beneficial microbiome. 
Further work with yeast, YC, and yeast extracts needs to be conducted on poultry. Much 
of the discussion in the current review was based on the results from yeast products applied to 
animals and humans but not poultry. To gain an accurate sense of the effects in poultry, such 
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experimentation needs to be conducted in poultry (in vitro and in vivo). Additionally, many of 
the metabolites mentioned previously were investigated independent of yeast, YC, or yeast 
extract. It would be beneficial to assess the impact of metabolites and components from yeast 
individually as well as when combined. This would allow for the identification of beneficial 
metabolites and their respective individual and combined functional impacts on the 
corresponding host. 
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Table 1.1: Commonly researched feed additives for host health, including growth promotion 
and pathogen prevention, used in animal feed, their modes of action, and reviews for reference. 
Compound What they do How they work 
Reviews 
for 
reference 
Prebiotic Food ingredient to act 
as substrate for 
beneficial bacteria in 
the host GIT 
microbiota 
Host consumes prebiotic and it 
endures through the GIT relatively 
intact to the lower intestines where it 
selectively acts as substrate for 
beneficial bacteria 
22- 24 
Probiotic Live microbial 
microbial feed 
supplements that 
beneficially impact 
intestinal microbial 
balance 
Competes with pathogenic bacteria to 
colonize the intestines; ferments 
substrates to produce short- chain 
fatty acids; stimulated the immune 
response of the host.  
23, 25, 26 
Mannan-
oligosaccharide 
Specific 
oligosaccharide that 
inhibits pathogenic 
bacteria from binding 
the mucosal epithelial 
lining 
Pathogens have receptors specific for 
mannan residues, the pathogenic 
bacteria binds the manna and does 
not bind to the host epithelial cells. 
27- 29 
Organic acid Reduce the number of 
pathogens 
Undissociated form traverses the 
bacterial cell membrane; once inside 
the bacterial cell, the organic acid 
dissociates to produce H+ ions, 
which lowers the pH. The bacterial 
cell then has to expend its energy to 
restore its natural balance rather than 
promote its own growth. 
30- 34 
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Table 1 .2: Research conducted on commensal bacteria in the poultry GIT based on location. 
 
Host Site(s) Age(s) 
Commensal 
or pathogenic Method of investigation Reference 
Chicken Ileum, cecum 7, 13 days Commensal PCR based DGGE; 16S rRNA gene library 
analysis; qPCR 
69 
Chicken Cecum 4, 8, 14, 21, 35 days Commensal DGGE; RFLP 6 
Chicken Ileum, cecum 4 wk Commensal Percent G+C profiling 70 
Chicken Cecum, intestines 4, 14, 25 days Pathogenic Primer (species-specific) of 16S rDNA 71 
Chicken Cecum 1 day; 1, 2, 4, 6 wk Commensal TGGE; 16S rRNA gene sequencing 64 
Chicken Crop, ileum, cecum, 
rectum 
40, 41 days* Commensal 16S rDNA sequencing 72 
Chicken Ileum, cecum 28 days Commensal FISH with 16S rRNA oligonucleotides 73 
Chicken Crop, duodenum, 
colon 
2 mos Commensal FCM-FISH 74 
* Indicates differing rearing methods: conventionally raised and organically raised, respectively. 
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Table 1 .3: Suggested microorganisms for potential probiotic use based on various characteristics. 
aMixed culture composed of 29 cecal bacterial strains that have shown to inhibit Salmonella colonization.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Microorganism Host Site isolated Rationale Reference 
Enterococcus 
faecium 
Chicken Intestines Bacteriocin-producing ability 135 
Pediococcus 
pentosaceus 
Chicken Intestines Bacteriocin-producing ability 135 
Mixed culturea Chicken Cecum Inhibition ability of Salmonella 99, 136- 139 
Lactobacillus reuteri Chicken GIT β-glucanase gene enhances growth and nutrient digestion 140 
Lactobacillus 
fermentum 
Chicken GIT Intestinal adherence, pathogen inhibition, tolerance to gastric 
enzymes 
141 
Bifidobacterium 
longum 
Chicken GIT Anti-Campylobacter activity 142 
Streptococcus 
faecium 
Chicken GIT Impacts of body weight, feed conversion, carcass yield, 
Salmonella colonization 
143 
Streptococcus bovis Cattle Rumen Inhibition ability of Salmonella 144 
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Table 1 .4: Published reviews on the considerations of common prebiotics in various hosts. 
 
Prebiotic Considerations Host Reference 
Inulin-type Structure overview Not applicable 172 
Short-chain carbohydrates Gut function and health Human 175 
Inulin-type Bifidogenic, resistant to digestion Non-specific 176 
Resistant starch Production of SCFA, microbiome modulation, gut-associated 
immunomodulation 
Human 177 
Mannan-oligosaccharide Modulation of gut microbiome Poultry 27 
Fructo-oligosaccharide, galacto-
oligosaccharide, lactulose 
Criteria for prebiotic classification Human 168 
Inulin-type, oligofructose Quantification of inulin and oligofructose in Western diet Human 173 
Fructo-oligoaccharide Bifidogenic, lack of carcinogenic and toxic effects Poultry, Swine 174 
Fructo-oligosaccharide, inulin-type Selective to beneficial bacteria, prevent pathogen colonization Poultry 178 
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2.   Original-XPCTM effect on Salmonella enterica serovar Typhimurium and cecal 
microbiota from three different ages of birds when incubated in an anaerobic in vitro 
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ABSTRACT 
 Biological supplements are utilized in the poultry industry as a way to improve growth 
performance and reduce pathogen inhibition. Some of these supplements, for example prebiotics, 
are directed at working in concert with and in support of the microbiome of the lower intestinal 
tract of poultry. The current research evaluates the effects of Original-XPCTM (XPC), a product 
with activity hypothesized to be similar to prebiotics, on Salmonella survival in the cecal 
microbiome as well as modulation of the cecal microbiota via an anaerobic in vitro mixed culture 
assay. Cecal slurries from three individual birds at each of three sampling ages (14, 28, and 42 d) 
were generated and allowed a 24 h pre-incubation period with the various treatments: XPC (1% 
XPC with basal poultry diet + cecal slurry), negative control (NC with basal poultry diet + cecal 
slurry), XPC + Feed (1% XPC with basal poultry diet), and cecal only (cecal slurry). The XPC, 
NC, and XPC + Feed were all challenged with Salmonella enterica serovar Typhimurium and 
subsequently plated on selective media at 0, 24, and 48 h. Analysis of the cecal microbiota 
indicated increased species diversity and richness directly related to sampling age, while no 
significant differences were observed among treatments. However results revealed treatment 
with XPC significantly reduced the survival of S. Typhimurium at the 24 h plating timepoint for 
both the 28 and 42 d sampling ages; while S. Typhimurium reduction in the NC appeared to 
eventually reach the same level by the 48 h plating timepoint. These findings suggest that 1) 
XPC may be capable of accelerating the rate (24 h versus 48 h) at which the cecal microbiota is 
able to limit S. Typhimurium growth and 2) the maturity of the cecal microbiota may be critical 
in limiting S. Typhimurium in the ceca. The results observed may attest to the early age of the 
bird at which XPC needs to be supplemented in order to maximize efficiency.   
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INTRODUCTION 
Prebiotics are often used in the poultry industry as a replacement of antibiotic growth 
promoters; they are expected to maximize growth, while minimizing pathogen invasion by 
selectively stimulating only beneficial bacteria (Roberfroid, 2007). Prebiotics are defined as 
substances that travel past the upper gastrointestinal tract (GIT; resisting hydrolysis by gastric 
enzymes and degradation by acidic pH) remaining intact and acting as selective substrates for 
beneficial bacteria in the lower GIT in order to improve host health (Gibson and Roberfroid, 
1995; Roberfroid, 2007). However, the definition of a prebiotic is continually evolving as more 
becomes understood about the gastrointestinal microbiome (Hutkins et al., 2015). With this in 
mind, there are several food ingredients available that do not fit the stringent prebiotic definition 
as set by Gibson and Roberfroid (2005), yet provide advantageous influences to the host health. 
These food ingredients are known as prebiotic-like compounds (Roto et al., 2015). A common 
prebiotic-like compound is a Saccharomyces cerevisiae fermentation product (SCFP), which 
contains the fermentation products of S. cerevisiae along with metabolites, the media used in the 
fermentation, yeast cell wall fragments (including mannon-oligosaccharides and β- glucans), and 
residual live yeast cells (Shen et al., 2011). Original-XPCTM (XPC; Diamond V Mills, Cedar 
Rapids, IA) is a commercially available product similar to SCFP however it lacks any residual 
live yeast cells, allowing for an extended shelf life (personal communication, Diamond V Mills). 
Research regarding XPC has been conducted in several different animal model systems, both in 
vivo and in vitro, to investigate its effects on host health (Gao et al., 2008; Osweiler et al., 2010; 
Price et al., 2010).  
The compound XPC potentially falls into the category of prebiotic-like compounds. The 
mechanism of action is unclear, although it is suggested to have some immunological effects that 
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enable the host to ward off pathogen invasion. The current research utilizes an anaerobic in vitro 
mixed culture assay to mimic the chicken hindgut in order to quantify Salmonella survival.  The 
in vitro methodology allows for a more direct assessment of the performance of XPC, while 
reducing confounding host variables (for example, host immune response) and being more cost 
efficient (Polli, 2008). The study utilized three different sampling ages in order to observe the 
temporal effect on the cecal microbiota that has been reported in previous studies (Scupham, 
2009; Danzeisen et al., 2013; Oakley et al., 2014). Additionally, samples were taken at various 
time points for cecal microbiota analysis in response to treatment with XPC. In this study, we 
examine the potential of XPC treatment in the inhibition of Salmonella in the poultry host ceca 
and attempt to identify the mechanism of XPC. Furthermore, the current research characterizes 
the cecal microbial populations and evaluates the species diversity within the cecal microbiota as 
a result of XPC treatment and host maturity.  
MATERIALS AND METHODS 
Experimental Design 
This experiment contained two trials, each with three biological replicates (individual 
birds) utilized at each of the three time points: 14, 28, and 42 days.  
Salmonella Typhimurium Preparation 
This study used a chicken isolate of S. Typhimurium (strain ST 97) resistant to nalidixic 
acid (NA) to selectively identify this specific strain from a mixed microbial background. Bacteria 
were grown in 6 mL Luria Bertani (LB) broth with 20 μg/mL NA for 16 h with shaking at 37°C. 
Bacteria was washed in phosphate-buffered saline (PBS) three times and resuspended in 1 mL 
PBS. Optical density was measured at 600 nm with a spectrophotometer (Beckman Coulter Inc, 
Brea, CA). 
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Broiler Chicken and Cecal Preparation 
Animal handling and procedures conducted were in accordance with the guidelines of the 
University of Arkansas’s Institutional Animal Care and Use Committee (IACUC). Ten male 
broiler chicks (per trial) were obtained from Cobb-Vantress, Inc. (Siloam Springs, AR), grown in 
a pre-disinfected Horsfall unit, and provided antibiotic-free corn-based poultry feed and water ad 
libitum until 14, 28, and 42 days of age. Broilers were randomly tagged with leg bands, 
euthanized by CO2 asphyxiation, and their ceca were collected aseptically into sterile sample 
bags (VWR, Radnor, PA). The ceca were transferred into an anaerobic chamber (Coy Laboratory 
Products, Grass Lake, MI), the cecal contents (0.1 g) were weighed, and subsequently diluted to 
1:3000 in anaerobic dilution solution (ADS; 0.45 g/L KH2PO4, 0.45 g/L (NH4)2SO4, 0.9 g/L 
NaCl, 0.1875 g/L MgSO4-7H2O, 0.12 g/L CaCl2-2H2O, 1mL/L 0.1% resazurin, 0.05% cysteine-
HCl, and 0.4% CO2-saturated sodium carbonate). The ADS was prepared as originally described 
by Bryant and Robinson (1961), with cysteine-HCl added prior to autoclaving as described in 
Shermer et al. (1998).  
In Vitro Incubation  
The in vitro procedure was carried out as described previously (Donalson et al., 2007). 
Autoclaved serum bottles (100 mL) were prepared containing 0.5 g Torres Chick Starter (Table 
2.1) and 1% XPC. A 40 mL volume of diluted cecal contents was added to each serum bottle. All 
serum bottles were placed directly into incubation at 37°C for a 24 h pre-incubation and 
inoculated with S. Typhimurium at a final concentration of 107 bacteria/mL after the pre-
incubation. Contents were subsequently plated on LB + NA + novobiocin (NO) media to serve 
as the baseline (0 h incubation). Repeated plating occurred at 24 h and 48 h to determine S. 
Typhimurium survival. Each treatment group containing cecal contents, feed, and XPC (XPC) 
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was compared to three control treatments: 1) negative control (NC), 2) cecal only control (CO), 
and 3) XPC + Feed control (Table 2.1). The XPC + Feed control was added as a treatment after 
the 14 d sampling age in trial 1 to establish whether XPC was working alone or in concert with 
the cecal contents in the inhibition of S. Typhimurium. Aliquots of samples (2 mL) were 
collected at 0, 6, 12, 24, and 48 h for microbiome analysis for NC, CO, and XPC treatments. 
Microbiome Analysis via Illumina MiSeq 
Extraction of cecal DNA from aliquots of samples for microbiome analysis was 
conducted via QIAamp Fast DNA Stool Mini Kit according to the manufacturer’s protocol 
(Qiagen). The final step of the DNA extraction deviated from the manufacturer’s protocol which 
used DNase/RNase-Free distilled water in place of the elution buffer provided. Concentrations 
and purity of the cecal DNA samples were measured using the Nanodrop ND-1000 (Thermo 
Scientific, Waltham, MA).  
Polymerase chain reaction (PCR) was used to amplify the V4 region of the 16S rRNA 
gene with dual-indexed primers with an Eppendorf Mastercycler pro S (Eppendorf, Hamburg, 
Germany) according to the methodology described in Kozich et al. (2013). Confirmation of the 
amplification and size of PCR amplicons was conducted on 1% agarose gel. Invitrogen 
SequalPrep kit (Life Technologies, Carlsbad, CA) was utilized for the normalization of PCR 
amplicons according to the manufacturer’s protocol. The samples (5 µL of each sample) from 
each well were pooled together. For quantification of the pooled samples, the Eppendorf realplex 
Mastercycler ep gradient S (Eppendorf, Hamburg, Germany) was utilized with the KAPA 
Library Quantification Kit (KAPA Biosystems, Wilmington, MA) according to the 
manufacturer’s protocol (from Ct values of standard curve R2 = 0.999; efficiency = 96%). The 
length of the amplicon fragments was evaluated using the Agilent Bioanalyzer. Amplicons were 
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diluted to 4 nM with 0.2 N fresh NaOH and HT1 buffer, combined with prepared PhiX Control 
v3 (5%), and a final concentration of both reagent and library was produced at 6 pM. The index 
primer, Read 1 and Read 2 sequencing primers, and the sequencing library were subsequently 
loaded into an Illumina MiSeq reagent cartridge.  
Sequence and Statistical Analysis 
 Sequencing (FastQ) files were downloaded from the Illumina Basespace website 
consisting of both demultiplexed R1 and R2 sequencing reads (each one being approximately 
250 bp in length). Samples with less than 10,000 reads were excluded from analysis. Sequence 
analysis using the Greengenes database as the reference database, classification of operational 
taxonomic units (OTUs) among sequences sharing 97% identity, and species diversity and 
richness (Chao1 and Shannon Diversity Index) were evaluated via the Quantitative Insights Into 
Microbial Ecology (QIIME; Caporaso et al., 2010) pipeline. UniFrac principal coordinates 
analysis (PCoA) plots, generated via QIIME, were used to determine the multidimensional 
distances reflecting similarities and differences between samples based on age and treatment.  
 The JMP® Pro 12 (SAS Institute, Cary, NC) software was utilized for statistical analysis. 
One-way analysis of variance (ANOVA) and student’s t tests evaluated the statistical 
significance among microbial abundance data with a level of significance of less than 0.05.  
RESULTS AND DISCUSSION 
S. Typhimurium Survival in Treatment with XPC 
The first objective of the current research used the fermentation product, XPC, to 
examine its impact on S. Typhimurium in a mixed culture assay. The poultry ceca contain the 
largest number of bacteria due to the relatively slow digesta transit time (Salanitro et al., 1974). 
As the poultry host matures, the composition of the cecal bacteria become more diversified and 
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reach concentrations that allow them to maximize their metabolic fermentative activities in an 
anaerobic environment (Roto et al., 2015). The in vitro assay in the current study attempted to 
mimic the environment of the chicken ceca, providing chicken feed as the nutrient supply for the 
cecal contents while maintaining an anaerobic environment. The majority of the bacteria in the 
poultry ceca are strictly anaerobic, and have traditionally been enumerated using anaerobic jars 
and selective media (Fan et al., 1995; Ricke and Pillai, 1999).  
When considering the definition of prebiotics as set by Roberfroid (2007), XPC should 
reach the lower GIT without being hydrolyzed or digested. The methods in the current study 
demonstrate the potentially synergistic effects between XPC and the cecal bacterial populations 
based on the assumption that XPC is maintaining its activity until it reaches the ceca. Based on 
previous studies, the assay utilized a 24 h adaptation period of each sample containing cecal 
contents and poultry feed (Donalson et al., 2007). This allows the cecal bacteria to ferment and 
continue metabolism of substrates from both poultry feed, and in some cases XPC treatment, 
prior to being challenged with S. Typhimurium (Donalson et al., 2007). The 24 h adaptation 
period is necessary for XPC to inhibit Salmonella due to its prebiotic-like mechanism (affects the 
microbial ecology of the gut).  
Previous research has indicated the ability of XPC in animal cecal contents inhibit 
various pathogens as well as increase antibodies in blood samples (Jensen et al., 2008; Gao et al., 
2008). The current study followed in suit, indicating 0.5 to 3.0 log reduction in S. Typhimurium 
survival in treatment with XPC compared to the NC treatment. At the 14 d sampling age, there 
were no significant differences in the S. Typhimurium survival observed in the XPC treatment 
when compared to the NC in either trial, although there were numerical (approximately 1.0 log) 
reductions (Figures 2.1A and B). The results obtained at the 28 d sampling age varied among 
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trials. All reductions observed in the XPC treatment were significant at the 24 and 48 h plating 
timepoints at the 28 d sampling age in both trials (Figures 2.1C and D). However, the reductions 
observed in the XPC treatment in trial 2 were approximately 2.0 and 3.5 logs greater at the 24 
and 48 h plating timepoints, respectively, as compared to the trial 1. In the first trial at 28 d, the 
XPC treatments indicated approximately 1.0 and 3.0 log reductions in the S. Typhimurium 
recovered at both the 24 and 48 h timepoints as compared to the NC. While in the second trial at 
28 d, the XPC treatment revealed S. Typhimurium population levels to be 2.0 and 3.0 logs lower 
than the NC treatment in the 24 and 48 h plating timepoint respectively, with the recovery below 
the limit of detection of 10 CFU/ml (LOD) at the 48 h plating timepoint (Figures 2.1C and D). 
The variation observed between the two trials at the 28 d sampling age is potentially an indicator 
to the degree of microbial development (and, in turn, inconsistency) in the cecal microbiome. 
This may suggest that treatment with XPC, similar to other products intended to support the 
cecal microbiome and the immune system, may need to be administered at an earlier age in order 
to be effective in its reduction in S. Typhimurium (Sharma and Burmester, 1982; Nisbet, 2002; 
Bielke et al., 2003).  
At the 24 h plating timepoint for the 42 d sampling age, there were numerical reductions 
(between 1.0 and 2.0 logs) in both trials when comparing the XPC treatment and NC, with trial 2 
trial indicating significant differences (Figures 2.1E and F). By the 48 h plating timepoint at the 
42 d sampling age, there were no significant differences observed among any treatments, with 
the XPC treatment being below the LOD in both trials. What is interesting is that although there 
were numerical differences between the XPC and NC treatments, both treatments contained 
cecal contents and were able to reduce the level of S. Typhimurium present to the LOD by the 48 
h plating timepoint. This suggests the potential of the cecal microbiome adapting to the 
  
73 
environment and being able to possibly out compete S. Typhimurium for nutrients and/or 
generate an unfavorable environment by the production of short chain fatty acids (SCFA; Fooks 
and Gibson, 2002). 
The XPC + Feed control (containing no cecal slurry) indicated higher S. Typhimurium 
recovered compared to all treatments (XPC, NC, and CO) at all timepoints (14, 28, and 42 d; 
data not shown). The comparison of the results of the XPC treatment to the control containing 
only XPC + Feed control suggests the necessity of the cecal contents to exercise the mechanistic 
activity of XPC. The XPC + Feed control (containing no cecal slurry) revealed a 3.0 log 
reduction in the abundance of S. Typhimurium from the 0 h plating timepoint to the 48 h plating 
timepoints across all ages, while the XPC treatments (containing cecal slurry, feed, and XPC) in 
both trials exhibited much greater total log reductions (4.0 to 6.0 logs; Figures 2.2A to E).  
Cecal Microbiome Analysis  
In poultry, the most vulnerable time in the maturation to market age is early on in life 
when the intestinal tract is continuing to change both anatomically and physiologically, as well 
as the establishment of various bacterial strains along the intestinal epithelium (Schleifer, 1985; 
Iji et al., 2001; Brisbin et al., 2008). The stability of the cecal microbiota is directly related to 
age, as suggested by the increased variability observed among cecal microbiota composition in 
younger chickens (14 days) when compared to more mature chickens (28 days; Torok et al., 
2009). The transient bacterial populations in the cecal microbiota of younger animals indicate 
immaturity and potentially increased susceptibility to invasion by pathogenic bacteria while the 
stable diversity among cecal populations in a mature broiler GIT can lead to increased protection 
from pathogen invasion (Lozupone et al., 2012). Culture-independent analytical methods to 
characterize a given environment has become commonplace as it allows the study of the 
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microorganisms within that environment without prior culturing, thereby reducing the number of 
potential biases introduced by culture-based methods (Langendijk et al., 1995; Ricke and Pillai, 
1999; Amit-Romach et al., 2004; Wooley and Ye, 2010). Sequencing of samples allows for the 
evaluation of the variation of both the species diversity as well as the structure of the 
communities over time and space (Hamady et al., 2010). The analysis of the 16S rRNA gene 
using primers targeting a hypervariable region (V4 in the current research) provides the unique 
properties of ubiquity while being conserved with a domain region of differing evolutionary 
rates, thereby making it an ideal phylogenetic marker (Case et al., 2007; Caporaso et al., 2011). 
After filtering the sequences based on read quality and sample size, there were a total of 
135 samples in each of the two trials (45 samples per treatment total: three biological replicates 
at three sampling ages, each with five microbiome sampling timepoints) of the V4 region of the 
16S rRNA gene analyzed. Analytical information regarding the sequences generated revealed 
25,013,102 and 20,856,668 total reads and error rates (as determined by the bases within the 
reads that align with three errors or less to the PhiX control sample included in the run) of 2.05 
and 2.15% in the first and second trials respectively.  
The most abundant phyla identified in both trials were in accordance with that of 
previous research (Salanitro et al., 1974; 1978; Wei et al., 2013): Firmicutes (trial 1: 68.06 %; 
trial 2: 52.27 %), Proteobacteria (trial 1: 28.06 %; trial 2: 15.30 %), and Bacteroidetes (trial 1: 
1.04 %; trial 2: 30.13%; Figures 2.3A and B). Similar to the results in trial 2 of the current 
research, Firmicutes and Bacteroidetes have been identified as the most abundant phyla in the 
chicken cecal microbiota in culture-based studies (Salanitro et al., 1974; 1978; Figure 2.3B). The 
abundances of both Proteobacteria and Bacteroidetes in trial 2 as well as in previous studies are 
observed to be more variable (at the expense of the abundance of Firmicutes) with either 
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bacterial community ranging from less than 10% to greater than 30% abundance (Zhu et al., 
2002; Wei et al., 2013). The largest variation among trials was observed in Bacteroidetes, in 
which the observed abundance in trial 1 was less than has previously been observed (Wei et al., 
2013; Figure 2.3A). The variation observed between the trials suggest that there may have been 
uncontrolled environmental factors that resulted in distinct phyla abundances among all nine 
broilers utilized in trial 1 from the nine broilers used in trial 2. Trial 2 results are more typical of 
results observed within the lifespan of the cecal microbiota of healthy chickens (Zhu et al., 2002; 
Lu et al., 2003).  
 The order level analysis revealed Clostridiales to be most abundant in both trials relative 
to Enterobacteriales, Lactobacillales, and Streptophyta (Figures 2.4A and B). As could be 
expected, the Enterobacteriales were more abundant in trial 1 based on the large proportion of 
Proteobacteria at the phylum level, while in trial 2, the abundances of Lactobacillales and 
Enterobacteriales were more similar. At the family level characterization, Enterobacteriaceae 
(Proteobacteria phylum), Lachnospiraceae (Firmicutes phylum), and Ruminococcaceae 
(Firmicutes phylum) were the most abundant in both trials, with slightly increased 
Enterobacteriaceae abundance in trial 1 (Figures 2.5A and B). In a previous study, similar 
results, reported Lachnospiraceae to be most abundant, followed by Ruminococcaceae and 
Enterobacteriaceae in the cecal microbiota of chickens from 7 to 19 d (Videnska et al., 2013). 
Videnska et al. (2013) suggested that because infection with S. Enteritidis resulted in a decrease 
in Ruminococcaceae with a concurrent increase in Enterobacteriaceae, then S. Enteritidis could 
influence the composition of the cecal microbiota in chickens. The results in the current study are 
in agreement with this finding in the 14 d sampling age, which is within the range of sampling 
ages (7 to 19 d) taken by Videnska et al. (2013) (Figures 2.5A and B). It is possible that there 
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may be a degree of protection due to appropriate taxonomic balance based on the increased 
reduction of S. Typhimurium observed in trial 2 when compared to trial 1 (CO phylum and order 
abundances were not included in the figures as they were not challenged with S. Typhimurium 
and therefore unable to be correlated to reductions observed).  
Analysis at the genus level indicated Bacteroides, an unknown genus belonging to the 
family Enterobacteriaceae, and an unknown genus belonging to the family Lachnospiraceae to 
be the most abundant in all samples analyzed in trial 2 (Figures 2.6B). Both sequences identified 
as being related to Lachnospiraceae and Oscillobacter were identified in the current study, 
which is in accordance with previous studies (Gong et al., 2008; Luo et al., 2013; Videnska et al., 
2013; Oakley et al., 2014). The presence of both of these bacterial populations have been 
suggested to produce SCFA as well as play roles in the maintenance of the intestinal epithelial in 
different animal models (Lam et al., 2012; Lee et al., 2012; Oakley et al., 2014). Within each 
sampling age and treatment, differing genera were revealed to be most abundant. In trial 1, the 
unknown genus belonging to Enterobacteriaceae was most abundant through the sampling ages 
and treatments, while the Bacteroides (phylum Bacteroidetes) followed by Oscillospira (phylum 
Firmicutes) were most abundant in trial 2. The CO treatment exhibited the largest abundance of 
Faecalibacterium in both trials. As this treatment lacked a nutrient supply, these results suggest 
that Faecalibacterium may be capable of out-competing other bacterial communities in a nutrient 
starved environment. Faecalibacterium is recognized to have anti-inflammatory properties in 
human and murine models, and butyrate-producing properties in broiler supplemented with 
vitamins in their diets (Sokol et al., 2008; Louis and Flint, 2009; Luo et al., 2013). 
The temporal effects on species diversity and richness as evaluated by Chao1 index, 
observed OTUs, and phylogenetic diversity (PD) revealed that all three measurements follow the 
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same trend of directly increasing with age in both trials (Figures 2.7A to C). Trial 1 revealed 
larger variation, with detectable decreased measures in the 14 d compared with the later 
sampling ages (28 and 42 d), while trial 2 revealed significant increases in the 42 d compared to 
both of the early sampling ages (14 and 28 d). Increasing cecal microbiota complexity directly 
related to sampling age has been observed in previous studies in poultry intestinal microbiome 
analysis (Salanitro et al., 1974; Danzeisen et al., 2013; Oakley et al., 2014). Meimandipour et al. 
(2011) provided evidence for this by the variation in the production of SCFA observed in the 
ceca across various sampling ages. The rarefaction curves for the number of observed OTUs and 
the Chao1 index indicated the 42 d sampling age to be significantly increased when compared to 
the 14 and 28 d sampling ages (Figures 2.7A and C). The continued projection upward rather 
than a plateau indicates that further subsampling of sequences would increase the species 
richness, increase the numbers of OTUs, and add new branches to the tree of sequences resulting 
in increased PD (Figures 2.7A to C; Figures 2.8A to C). The trend when evaluating the OTU and 
PD rarefaction curves revealed CO to consistently have higher measures, with a significantly 
increased value in the PD rarefaction curve for trial 1 (Figure 2.8B and C). 
 The Shannon diversity index in both trials revealed no significant differences within a 
given treatment among the sampling ages except in XPC treated samples. The overall Shannon 
diversity indices were higher for the NC and XPC treatments in trial 1 when compared to trial 2 
(Table 2.2). What is interesting is that the XPC treatment exhibited the lowest Shannon diversity 
indices at the 14 d sampling age than any other treatment or sampling age in both trials, yet was 
the only treatment to significantly increase when compared to the 42 d sampling age. This may 
suggest the necessity of introducing XPC to the host at an earlier age in order to maximize the 
effects on cecal microbial diversity development. The increased diversity in the structure of the 
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cecal microbial communities is associated with weight gain at later stages of the market broiler 
lifespan (Lu et al., 2013). However, when considering that a broiler chicken does not begin 
puberty until 210 days of age, the broiler cecal microbiomes identified in recent studies are very 
young and therefore may not reach the optimum diversity for maximized broiler growth 
(Danzeisen et al., 2013; Lu et al., 2013; Oakley et al., 2014). 
 The UniFrac Principle Coordinate Analysis (PCoA) plots indicated significant 
differences in the weighted and unweighted plots when observing the influence of sampling age 
and treatment in both trials. There was no clustering visible in any of the weighted PCoA plots 
based on sampling age or treatment in either trial (Figures 2.9A to D). However in the 
unweighted plots there was distinct clustering visible in both the sampling age and treatment in 
both trials (Figures 2.10A to D). The unweighted PCoA plot revealed the CO control to cluster in 
both trials while there were two mixed groups consisting of mixtures of NC and XPC treatment 
suggesting there to be no distinguishable effect from treatment with XPC based on clustering 
(Figures 2.10A and C). Similar clustering was observed in the unweighted PCoA plots in trial 2 
based on age, revealing 14 and 42 d samples to clustering into their own respective groups while 
28 d samples were less clustered and overlapped into both 14 and 42 d clusters (Figure 2.10D). 
CONCLUSIONS 
 Research conducted evaluating the effectiveness of feed additives seeking to fill the gap 
left as a consequence of the retraction of antibiotic growth promoters (AGPs) from animal feed 
are commonplace. What has been recognized in the current research along with previous work is 
that feed additives, aside from vitamins (Luo et al., 2013), are appearing to have little impact on 
the composition of the cecal microbiome in general (Denzeisen et al., 2013; Oakley et al., 2014). 
The current study reviewed the influence of XPC on the inhibition of S. Typhimurium and 
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reported that there was initial prevention, however the level of reduction eventually became 
equal among all of the treatments containing cecal contents. These findings suggest the ability of 
XPC to accelerate the rate at which S. Typhimurium and possibly other pathogens are inhibited 
by the cecal microbiota. Other studies more dramatically portray the influential abilities of XPC 
in various animal models, indicating an influential “host” factor (GIT morphology, immunologic 
response, growth performance, and pathogen reduction; Gao et al., 2008, 2009; Jensen et al., 
2008; Osweiler et al., 2010).  
There were significant observations regarding the successional changes in microbiome 
complexity that have not been previously observed with feed additives (Denzeisen et al., 2013; 
Lu et al., 2003; Oakley et al., 2014). With the shift in diversity, there may be related shift in the 
physiological functions performed by the microorganism present (Lu et al., 2003). Because 
antibiotic growth promoters have thus far indicated the ability to promote growth while limiting 
pathogens in poultry, it would be beneficial to characterize the intestinal microbiome when 
supplemented with AGPs, and compare the intestinal microbiome to that produced from various 
feed supplements (probiotics, prebiotics, synbiotics). For the poultry industry to utilize the 
current research, it may be beneficial to accelerate development of the intestinal microbial 
complexity of the broiler host by using supplements that interact with the host intestinal 
microbiome and promote a diversity related to its maturity.  
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Table 2 .1: Ingredient composition of the Torres Chick starter diet. 
Ingredient Composition of Total (%) 
Corn 63.07 
Soybean meal 25.75 
Fat 2.85 
Calcium carbonate 1.03 
Dicalcium phosphate 1.10 
Salt 0.40 
DL methionine 99.5 0.28 
Trace minerals 0.10 
Choline chloride 60% 0.22 
Vitamin premix 0.20 
ProPack 5.00 
 
 
 
 
 
 
 
 
 
Table 2 .2: Shannon diversity index based on treatment and sampling age within their respective 
trials. Samples are analyzed for significant differences within a treatment at the various sampling 
ages. 
Trial 1     
  Sampling Age (days) 
 Treatment 14 28 42 
 XPC 1.89B 2.31AB 2.35A 
 NC 1.96 2.08 2.17 
 CO 2.15 2.31 2.27 
Trial 2     
 XPC 1.75B 1.91AB 2.04A 
 NC 1.92 1.82 1.92 
 CO 2.17 2.21 2.28 
XPC = XPC treatment; NC = negative control; CO = cecal only control. 
Differing letters within a treatment reveal significant differences (P > 0.05).  
Lack of numbers indicates no significance differences among Shannon diversity indices within 
the treatment group.  
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Figure 2 .1A to F: S. Typhimurium survival amond treatments (XPC = XPC treatment; 
NC = negative control; CO = cecal only): A) trial 1- 14 day old chickens, B) trial 2- 14 
day old chickens, C) trial 1- 28 old chickens, D) trial 2- 28 day old chickens, E) trial 1- 
42 day old chickens, and F) trial 2- 42 day old chickens. Differing letters indicate 
significant differences (P < 0.05). 
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Figure 2. 1A to E: S. Typhimurium survival comparing XPC + Feed Control and XPC 
treatment: A) trial 2- 14 d chickens, B) trial 1- 28 d chickens, C) trial 2- 28 d chickens, D) trial 1- 
42 d chickens, and E) trial 2- 42 d chickens. No figure for trial 1- 14 d chickens is presented as 
data for XPC + Feed Control was not collected at this timepoint. 
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Figure 2. 2A and B: Relative abundances of Firmicutes, Bacteroidetes, and Proteobacteria based 
on treatments (NC and XPC) and sampling age in A) trial 1 and B) trial 2. 
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Figure 2 .3A and B: Relative abundances at the order level based on treatments (NC and XPC) 
and sampling age in A) trial 1 and B) trial 2. 
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Figure 2 .4A and B: Relative abundances at the family level based on treatments (NC and XPC) 
and sampling age in A) trial 1 and B) trial 2. 
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Figure 2 .5A and B: Genus level relative abundances of the cecal microbiota samples at various sampling ages among all treatments. 
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Figure 2 .6A to C: Rarefaction curves of cecal microbiome samples based on sampling age 
displaying A) Chao1 index measuring species richness, B) observed OTUs, and C) phylogenetic 
distance measuring phylogenetic diversity by sampling depth. Asterisk (*) indicates significant 
difference (P < 0.05). 
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Figure 2 .7A to C: Rarefaction curves of cecal microbiome samples based on treatment 
displaying A) Chao1 index measuring species richness, B) observed OTUs, and C) phylogenetic 
distance measuring phylogenetic diversity by sampling depth. Asterisk (*) indicates significant 
difference (P <  0.05). 
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Figure 2 .8A to D: UniFrac weighted PCoA plots of A) trial 1 based on treatment, B) trial 1 
based on sampling age, C) trial 2 based on treatment, and 4) trial 2 based on sampling age. 
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Figure 2 .9A to D: UniFrac unweighted PCoA plots of A) trial 1 based on treatment, B) trial 1 
based on sampling age, C) trial 2 based on treatment, and 4) trial 2 based on sampling age. 
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ABSTRACT 
Biological supplements in poultry feed are of continued interest due to the improvements 
on growth performance, protection from pathogen invasion, and benefits on overall host health. 
The fermentation metabolites of Diamond V Original XPCTM (XPC) have previously been 
shown to improve commercial performance and reduce Salmonella in poultry. The current study 
sought to characterize the cecal microbiota using culture-independent analysis of the 16S rRNA 
gene in Coccivac-D sprayed broilers supplemented with XPC and/or Salinomycin (SAL). Ross 
708 male broilers (n = 1280) were assigned to one of four possible treatments: Cocci-vaccine 
(T1), Cocci-vaccine + XPC (T2), Cocci-vaccine + SAL (in the grower diet only) (T3), and 
Cocci-vaccine + SAL (in the grower diet only) + XPC (T4). Analysis with a PCR-based 
denaturing gradient gel electrophoresis (DGGE) indicated a shift in the microbial populations 
present at the various sampling ages, 16, 28, and 42 d. Phylogenetic analysis indicated further 
consistency in microbial communities directly related to bird age. Identification of microbial 
communities present and the assessment of their respective quantities using Illumina MiSeq 
sequencing indicated treatment with XPC had no significant impact on microbial diversity 
(Shannon diversity index, Chao1 index, observed OTUs). Sampling age revealed significantly 
greater diversity at 28 and 42 d (P < 0.05) as compared to the 16 d for Shannon diversity index, 
while showing significantly increased richness and diversity in the 42 d sampling age (Chao1 
and observed OTUs; P < 0.05). The results of the current study indicate that the chicken 
intestinal microbiota is impacted more by temporal changes rather than by the feed additive 
studied. 
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INTRODUCTION 
Poultry researchers are attempting to find alternatives to antibiotic growth promoters 
(AGP) in poultry diets, which are being restricted for use in food animal production (HHS, 
2015). The elimination of AGPs are due to concerns surrounding antibiotic resistance genes 
being transferred to humans through both the consumption of and contact with farm animals, 
rendering treatment with certain antibiotics ineffective (Witte, 1998). Various compounds have 
been and continue to be investigated for their ability to replace AGPs; one possible alternative is 
the fermentation metabolites of Diamond V Original XPCTM (XPC) (El-Husseiny et al., 2008; 
Kassem et al., 2012; Salim et al., 2013). The product XPC is a fermentation product that when 
fed in poultry diets has been shown to inhibit the survival of Salmonella while improving growth 
performance and health of poultry (El-Husseiny et al., 2008; Lensing et al., 2012; McIntyre et 
al., 2013; Carlson et al., 2016). A proposed mode of action for products similar in content to 
XPC (fermentation products) indicated the stimulation of diverse microbial communities in the 
gastrointestinal tract (GIT) of piglets (Kiarie et al., 2011).  
The poultry GIT microbiome has elicited interest due to the potential health impacts it 
may have on the host (Brisbin et al., 2008; Hoffmann et al., 2009; Roto et al., 2015). The host-
microbiome interactions may affect the host immune system, provide protection against 
epithelial damage, and increase nutrient availability and digestibility (Spring et al., 2000; Hooper 
et al., 2001; Brisbin et al., 2008; Jensen et al., 2008; Hoffmann et al., 2009). However, the 
poultry microbiome has a complex population of diverse microorganisms, the majority of which 
are of not-yet-identified species (Gong et al., 2002; Zhu et al., 2002; Ballou et al., 2016). 
Identification and/or development of feed additives that are capable of targeting the GIT 
microbiome and the specific microbial populations that have proven to be capable of improving 
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both health and growth performance would of great importance. Identifying the microbiome 
species and their respective abundances in a recognized mature and healthy poultry host would 
be the next logical step. 
The objective of the current study was to identify the impact of feeding XPC on cecal 
microbial populations, and their relative abundances, present in the poultry GIT microbiome in 
response to treatment with XPC and/or Salinomycin (SAL). To eliminate known biases of 
culture-based methods, this objective was conducted using an Illumina MiSeq platform 
following preliminary data obtained via PCR-based denaturing gradient gel electrophoresis 
(DGGE).  
MATERIALS AND METHODS 
Experimental Design 
 A total of 1,280 day-old Ross 708 male broilers were sprayed with Coccivac-D (Merck, 
Kenilworth, NJ) and subsequently vaccinated (Marek’s Infectious Bursal Disease, Newcastle 
Disease, and Infectious Bronchitis) at the hatchery. The birds were transferred to a grow-out 
facility and randomly assigned to one of four possible treatments as described in Table 3.1. 
There were 64 total floor pens used in this experiment, eight pens per block, eight blocks in total. 
The birds were assigned to pens (1.22 m x 1.22 m) using a randomization table; the density was 
set to that of commercial stocking density, 0.23 m2. Each pen contained a Chore-Time feeder pan 
(Chore-Time Poultry Production Systems, Milford, IN) with a feed hopper above a reservoir and 
a nipple drinker (three nipples). Pens contained re-used pine shavings for bedding.   
A pelleted three phase feeding plan was implemented including a starter (0 to 16 d), 
grower (16 to 28 d), and finisher (28 to 42 d) diet. Feed and water was provided ad libitum. The 
inclusion rate of XPC in the starter and grower diets (for the birds receiving XPC treatment) was 
1.25 g/kg and subsequently reduced to 0.625 g/kg in the finisher diet. The inclusion rate for SAL 
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was a constant 0.044 g/kg in the grower diet only. The basal poultry diet contained no additional 
anti-coccidial or antimicrobial products prior to the treatment with SAL.  
A review by the University of Arkansas Institutional Animal Care and Use Committee 
(IACUC) was exempt because the birds were raised in an off-campus commercial farm 
operation. The current study was restricted to microbiological evaluation of birds selected on 
site. The commercial cooperators used internal animal welfare protocols based on the National 
Chicken Council (NCC) guidelines (www.nationalchickencouncil.org). 
Cecal DNA Extraction 
 
At 16, 28, and 42 d, 24 birds (three birds per pen per treatment) were randomly chosen 
for cecal content removal. All cecal DNA extraction utilized the QIAamp Fast DNA Stool Mini 
Kit according to the manufacturer’s manual (Qiagen, Valencia, CA) with the exception of using 
UltraPure DNase/RNase-Free Distilled Water (50 μl; Life Technologies, Carlsbad, CA) rather 
than using the provided buffer to elute DNA. Concentrations and purity measurements of the 
DNA were obtained with a Nanodrop ND-1000 (Thermo Scientific, Marietta, OH).  
Preparation of DNA Samples for DGGE 
 
Samples for DGGE analysis were pooled based on age and treatment group (each week 
of samples was separated into 16 pooled groups, 6 samples per group, 4 groups per treatment) to 
fit within the gel capacity. A polymerase chain reaction (PCR) was used to amplify the variable 
V3 region of the 16S RNA gene conserved region among bacteria; the primers used were 
described in Muyzer et al. (1993) (F: CGC CCG CCG CGC GCG GCG GGC GGG GCG GGG 
GCA CGG GGG GCC TAC GGG AGG CAG CAG; R: ATT ACC GCG GCT GCT GG). PCR 
amplification were performed in Peltier Thermal Cycler-200 (MJ Research, Inc., Waltham, MA) 
in reaction tubes (0.2 ml) containing 25 μl total volume: 15 μl JumpStart Taq ReadyMix (Sigma-
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Aldrich, St. Louis, MO), 2000 nM forward primer, 2000 nM reverse primer, 1 μl of 50 ng DNA, 
12 μl UltraPure DNase/RNase-Free Distilled Water (Life Technologies, Carlsbad, CA). The PCR 
analysis was performed with an initial denaturation step of 94°C for 5 min for DNA denaturation 
and held for 1 min. The temperature was subsequently decreased to 67°C for 45 s (-0.5/cycle), 
and extension at 72°C for 2 min; these steps were repeated for 17 cycles excluding the initial 
denaturation step. The program continued for 1 min at 94°C and 58°C for 45 s, and this sequence 
was repeated for 12 cycles. A final extension at 72°C for 7 min was performed; samples were 
held at 4°C. Negative controls using water were carried out for all amplifications performed. 
PCR amplification products were ensured via 1% agarose gel electrophoresis with ethidium 
bromide in 1X TAE buffer, stained, and visualized using a UV transilluminator; each gel run 
contained a 100 kb marker. Samples were diluted to 25 ng/μl in preparation for DGGE. 
DGGE and Phylogenetic Tree Generation 
 
The DGGE gels were cast with 8% acrylamide stock solutions and contained a gradient 
from 35 to 55% urea denaturant. Electrophoresis was carried out for 16 h at 55V and a 
temperature of 59°C using the DCode Universal Mutation Detection System (Bio-Rad 
Laboratories, Hercules, CA). After electrophoresis, the gel was stained using 20 μl of SYBR 
green in 650 ml 1X TAE on a shaker at 4°C for 40 min, and subsequently destained in distilled 
water for 10 min on a shaker at 4°C. Images of each gel were taken using a UV transilluminator 
to minimize the exposure of DNA bands to UV light exposure. DGGE gel images were uploaded 
to Quantity One software (Bio-Rad Laboratories, Hercules, CA) for phylogenetic tree analysis 
based on the unweighted pair group method with arithmetic mean (UPGMA) algorithm.  
Library Preparation for Sequencing 
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Individual bird samples were utilized for sequencing unlike in the DGGE analysis, which 
used pooled samples. PCR was used to amplify the V4 region of the 16S rRNA gene with dual-
indexed primers as described in Kozich et al. (2013). The primer mixture (F and R; 500 nM), 
DNA (10 ng/μl), and Accuprime Pfx SuperMix (Life Technologies, Carlsbad, CA) were 
combined in a 96 well plate, each plate contained one negative control (H2O). PCR amplification 
was performed in Eppendorf Mastercycler pro S (Eppendorf) using the following PCR 
conditions: 95° for the initial 5 min, followed by a cycle of 95° for 30 s, 55° for 30 s, 72° for 1 
min for 30 cycles, and ended at 72° for 5 min. PCR confirmation was conducted on 1% agarose 
gel of thirty randomly selected samples and one negative control from each plate. 
Normalization of PCR amplification products was performed using Invitrogen 
SequalPrep kit (Life Technologies, Carlsbad, CA) according to the manufacturer’s protocol to 
remove any salts or free primers. Confirmation was performed on 1% agarose gel of thirty 
randomly selected samples and one negative control from each plate. The samples from each 
well in each plate were pooled together, with the exception of the negative controls. Pooled 
samples from each plate were run on 1% agarose gel, DNA was extracted from each gel, and the 
concentration was measured using a Qubit Fluorometer (Life Technologies, Carlsbad, CA) 
according to the manufacturer’s protocol.  
Quantification of the pooled samples (each plate’s pooled sample and all the plates’ 
pooled samples combined) was conducted using both the Eppendorf realplex Mastercycler ep 
gradient S (Eppendorf, Hamburg, Germany) as well as the Agilent Bioanalyzer. KAPA Library 
Quantification Kit (KAPA Biosystems, Wilmington, MA) was followed according to the 
manufacturer’s protocol (R2 = 0.999; efficiency 96%). Amplicon lengths from the quantification 
were diluted to 4 nM. The sequencing library was combined with 0.2 N fresh NaOH and HT1 
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buffer to a concentration of 6 pM; PhiX Control was also prepared with 0.2 N fresh NaOH and 
HT1 buffer to a concentration of 6 pM; both the sequencing library and the PhiX Control were 
combined and loaded into the MiSeq reagent cartridge, along with the index primer and Reads 1 
and 2 sequencing primers.  
Sequence Analysis 
 
Both of the demultiplexed R1 and R2 sequencing reads of approximately 250 bp in length 
were generated and downloaded from the Illumina Basespace website. Sequences obtained with 
fewer than 1000 reads were omitted from analysis and sequences were re-analyzed excluding 
these samples. The Quantitative Insights Into Microbial Ecology (QIIME ver. 1.9.0; Caporaso et 
al., 2010) pipeline was used to analyze sequences and classify into operational taxonomic units 
(OTUs) based on 97% sequence identity (Greengenes database used as the reference database) 
into the phylum, order, genus, and species taxonomic levels. Alpha and beta diversity generated 
data regarding observed OTUs, Chao1 index, Shannon diversity index, and weighted and 
unweighted UniFrac distance among samples, respectively. 
Statistical Analysis 
 
Data from growth performance were separated for comparison by treatment. Statistical 
analysis was conducted using JMP® Genomics (SAS Institute, Cary, NC) with means separated 
using LS Means (P < 0.05).  The pen was the experimental unit for performance. Means of each 
data set from microbial prevalence were compared using ANOVA (one-way analysis of 
variance) test with a level of significance at 0.05. Species diversity and richness were assessed 
with QIIME by operational taxonomic units (OTUs), Shannon diversity index, and Chao1 (Chao, 
1984; Zhang et al., 2015). A probability of less than 0.05 was considered significant. UniFrac 
 110 
 
Principle Coordinate Analysis (PCoA) plots were generated through QIIME to illustrate the 
weighted and unweighted distances between samples based on sampling age.  
RESULTS AND DISCUSSION 
Analysis of Cecal Microbiota Shift Using PCR-Based DGGE 
 
 The objective of the current study included the investigation into the GIT microbiome, 
which has been attempted previously utilizing various methods. The culture-based methods used 
appear to be incomplete and selective in their results when considering the broader diversity of 
results obtained when using modern molecular and sequencing techniques (Bjerrum et al., 2006). 
Bjerrum et al. (2006) discusses the biases observed in culture-based methods that result in known 
bacterial species being identified and compares these methods to molecular methods, which 
revealed that only approximately 10% of the cecal bacterial species can be identified culturally, 
leaving the majority of species present as unknown (Salanitro et al., 1978; Mead, 1989; Ricke 
and Pillai, 1999; Apajalahti et al., 2004). Based on these biases, preliminary experimentation 
using DGGE was applied to assess the overall responses of the cecal microbial communities to 
various treatments and sampling ages. The technique of DGGE has been considered a reliable 
and relatively inexpensive pre-screening method for the quantification and diversity assessment 
of microbial populations present in an environment (Hanning and Ricke, 2011).  
All amplification products generated from PCR were 233 bp in length. The microbiota 
analysis via DGGE indicated a shift in the presence and relative abundances (determined via 
band brightness) of microbial populations in response to the treatment as well as bird maturity. 
Pooled samples from DGGE of the 16 d samples indicated randomness in banding patterns, with 
no clustering among the treatment groups (Figure 3.1A), while 28 and 42 d samples exhibited 
increased successional consistency, both in the banding patterns and the brightness of the bands 
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(Figure 3.1B and C). This is also reflected in the phylogenetic tree that was generated in the 
clustering of samples according to treatment; there appeared to be approximately 73.5% 
homology among samples treated with XPC (T2 and T4) at the 42 d sampling age, as shown in 
Figure 3.1C. This enhanced banding stability directly related to bird maturity and treatment with 
XPC indicates a potential effect of XPC to accelerate the rate at which microbial communities 
reach mature levels in the ceca. Past and current literature, as reviewed by Schneitz (2005), 
asserts the beneficial impact of having a mature microbiome with robust communities of various 
microorganisms. A mature microbiome can allow for enhanced growth performance, pathogen 
control, reduced mortality, and overall health of the host (Patterson, 2011). Feed additives, such 
as XPC, that appear to be capable of supporting development of the microbial cecal populations 
to reach mature abundances at an earlier age may permit more productive bird growth throughout 
the production period with less pathogen infection (Brisbin et al., 2008; Patterson, 2011).  
QIIME Analysis 
Given the initial indication of microbial shifts occurring due to the treatment and age of 
the bird, a more detailed characterization of the microbial populations present and their 
abundances via the Illumina MiSeq platform was performed. Conducting both DGGE and 
sequence analysis allowed for comparative insight between the two methods. After filtering 
sequences using read quality and sample size requirements, there were a total of 280 samples (94 
samples from individual birds at 16 d, 92 samples from 28 d, 94 samples from 42 d) of the V4 
region of the 16S rRNA gene analyzed. Based on the Illumina Basespace, the analytical 
information regarding the sequences generated the following: 27,167,116 reads in total at a 
1.49% error rate. The numbers of taxonomy groups identified (Edgar, 2010) were 19, 65, and 
244 at the phylum, order, and genus levels respectively, when analyzed using Greengenes Core 
reference alignment (DeSantis et al., 2006).  
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Greater than 99% of the sequences from all the samples at all age points belonged to one 
of the five most populated bacterial phyla, namely Firmicutes (78.2%), Bacteroidetes (14.8%), 
Proteobacteria (3.5%), Tenericutes (1.9%), and Cyanobacteria (0.9%). The data analyzed at the 
phylum level indicated Firmicutes to be significantly greater than all other phyla among all 
treatments and all sampling ages except for XPC with SAL at 42 d (Figure 3.2A to D). Wei et al. 
(2013) found similar results to the current study in that chicken cecal microbiome samples 
comprised primarily of Firmicutes, Bacteroidetes, and Proteobacteria at approximately 70, 12, 
and 9% respectively. The abundances of Firmicutes among all samples at all sampling age points 
in the current study were approximately 70 to 80% (Figure 3.2A to D). Generally, Firmicutes are 
recognized for their production of butyric acid, which is associated with pathogen inhibition (den 
Besten et al., 2013).  Bacteroidetes was revealed to be the second most abundant phyla among all 
treatments at each sampling age (Figure 3.2A to D). In contrast to Firmicutes observed 
abundances, the frequencies of Bacteroidetes were significantly decreased from the 28 to the 42 
d sampling ages (Figures 3.2A to D). The less abundant phyla of the five (Proteobacteria, 
Tenericutes, and Cyanobacteria) revealed no significant differences across ages with the various 
treatments with the exception of Proteobacteria at the 16 d sampling age in T2 (Supplementary 
Figure 3.1A to C). Although there were no significant differences at the phylum level analysis 
among the treatments at each sampling age (Supp. Figure 3.1A to C), significant differences 
were observed when comparing the sampling ages of each treatment (Figures 3.2A to D), 
indicating a more temporal effect on the composition of the cecal microbiome. Oakley et al. 
(2014) also observed bird maturation to have greater influence on the cecal microbial 
populations than the addition of feed additives in the diet.  
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Similar to the phylum level, the five most abundant Order level microbial populations 
occurring among the treatments at each sampled time point with their total respective 
percentages were Clostridiales (75.8%), Bacteroidales (14.8%), Enterobacteriales (3.5%), RF39 
(1.6%), and Lactobacillales (1.3%). In analyzing the order level microbial communities, as 
shown in Figures 3.3A to D, the microbial communities were not significantly different among 
treatments with the exceptions of Clostridiales at 16 d and Bacteroidales at 28 d, both being 
significantly decreased with treatment in comparison to the control. What is interesting in the 
Order level abundance analysis among age data is that Clostridiales significantly increased from 
28 to 42 d sampling ages while Bacteroidales significantly decreased from 28 to 42 d sampling 
ages (Figure 3.3A to D).  
Genus level evaluation of the cecal microbial populations indicated that eight abundant 
genera of bacteria were present for all sampling ages. Faecalibacterium and an unknown genus 
belonging to the Enterobacteriaceae family were present in samples at all three age points 
(Figure 3.4), decreasing in abundance with bird maturity. Faecalibacterium, a beneficial 
bacterium commonly observed in the both poultry and human intestinal tracts conferring anti-
inflammatory properties and production of butyric acid, decreased as the birds matured (Miquel 
et al., 2013; Oakley et al., 2014). Presence and consistent abundance of Oscillospira, an 
unknown genus belonging to the Ruminococcaceae family, and an unknown genus of the 
Clostridiales family are evident throughout the sampling age points; all of these genera have 
been previously observed in a 16S rRNA- based analyses of the poultry cecal microbiota in an in 
vitro mixed culture assay (unpublished data). An unknown genus belonging to the Rikenellaceae 
family appeared to be in greatest abundance in 28 d samples when compared to both 16 and 42 d 
samples. Although these are recognized as beneficial bacteria, this observation of reduced 
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abundance with maturity may be aligned with the hypothesis that each bacterial community 
reaches a balanced and stable level in the microbiome (Patterson, 2011). Conversely, an 
unknown genus of the Lachnospiraceae family appeared to be lowest in abundance at 28 d, with 
higher abundances in both 16 and 42 d samples. Bacteroides abundance appears to be directly 
related to bird maturity. Bacteroidetes, the class to which Bacteroides belongs, is recognized to 
have a beneficial relationship with the host microbiome, allowing the ability to stimulate the host 
immune system to control competing microorganisms that may be present in the environment 
(Mazmanian et al., 2005; 2008).  
 Analysis at the species level identified 292 distinctive species being present in the cecal 
microbiota, however the majority (81.8%) of those species have not yet been identified in the 
reference database. The most abundant identified species, shared among all ages of birds, were 
Faecalibacterium prausnitzii (7.6%), Bacteroides fragilis (2.4%), Blautia producta (0.3%), 
Gallibacterium genomosp. (0.1%), and Eggerthella lenta (0.1%) (Figure 3.5), however there 
does not appear to be a correlation of species abundance with either dietary treatment or bird 
maturity. The bacterial species F. prausnitzii is recognized as a beneficial microorganism and is 
considered commensal among the microorganisms in the poultry GIT microbiome (Bjerrum et 
al., 2006). In healthy humans, F. prausnitzii comprises between 5 and 15% of the fecal 
microbiota and is a well-known producer of butyrate (Scupham, 2007; Flint et al., 2012; Miquel 
et al., 2013). Butyrate is identified as playing a major role in GIT physiology, allowing for 
protection from pathogen invasion as well as modulating the host immune system (Macfarlane 
and Macfarlane, 2011). B. fragilis has previously been isolated from chicken cecal contents and 
is a producer of both succinic and acetic acids (Salanitro et al., 1974). The remaining three 
identified species, although occurring at minimal percentages, were B. producta, G. genomosp., 
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and E. lenta. Previously isolated from poultry, G. genomosp. appears to be pathogenic in nature 
and associated with mortality in various avian species (Christensen et al., 2003). The species E. 
lenta is also pathogenic, it is commonly observed in humans causing ulcerative colitis (Gardiner 
et al., 2014). Although F. prausnitzii, B. fragilis, B. product, G. genomosp., and E. lenta were the 
most abundant identified species, there were many more (30 total) unidentified species 
comprising of much higher abundances among the most dominant species.  This attests to the 
limited degree to which identification of bacterial species exists.  
Evaluation of the observed OTUs and Chao1index indicated significant differences 
among the sampling ages of 16 and 28 d when compared to 42 d (P = 0.003; Figure 3.5A and B). 
The determination of numbers of OTUs and Chao1 index revealed no significant differences 
when comparing the various treatments (Figure 3.6A and B). The Shannon diversity index at the 
species level revealed significantly increased diversity at both 28 and 42 d sampling ages when 
compared to the 16 d sampling age (Figure 3.6A). However, comparison of Shannon diversity 
index among treatments revealed no significant differences (Figure 3.7B). PCoA plots based on 
sampling age generated from QIIME analysis indicated significant differences in both weighted 
and unweighted plots (P = 0.001; Figure 3.8A and B). There is sectioning with overlap among 
sampling ages in the unweighted PCoA plot, while tighter clustering with 42 d samples in the 
center. When comparing the PCoA plots from sequencing to the DGGE banding patterns, there 
are correlations linking OTU abundance to be the primary driving force behind clustering 
observed in both the weighted PCoA plot and the 42 d DGGE gels (Figures 3.8B and 3.1C, 
respectively). 
Inclusion of XPC appears to allow for the microbial communities comprising the entire 
microbiome to reach their stable levels at an earlier age, as is indicated by DGGE analysis, 
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however this findings was less evident in the Next Generation Sequencing (NGS) data obtained. 
It has been suggested that the stable microbiome allows for increased digestion and nutrient 
absorption by the host GIT, in turn causing improved growth performance and feed conversion 
ratios (Brisbin et al., 2008; Hoffman et al., 2009; Delzenne et al., 2011). However, bird age 
appeared to be more influential on the species diversity, richness, and relative abundances, as is 
made evident by the Shannon diversity index, Chao1 index, observed OTUs, and weighted PCoA 
plots, respectively (Figures 3.5A, 3.6A and B, and 3.7B). There are several potential factors that 
may have affected the results observed, one being due to age in which the treatments were added 
as well as the decreased amount of XPC added in the diet from 28 to 42 d (0.625 g/kg) in 
comparison with 0 to 28 d (1.25 g/kg). A dosage effect of XPC has previously been observed to 
be influential on the growth performance and feed conversion ratio in poultry (El-Husseiny et al., 
2008). The current results indicate the necessity for further research on matching the appropriate 
dosage to the age of the bird over the growth cycle for GIT bacterial selection and establishment 
of a mature GIT microbiota (Hanning and Diaz-Sanchez, 2015). An essential part to the 
improved growth performance as observed in AGP treated animals, is the establishment of stable 
bacterial populations that will not utilize all the nutrients, rendering them unavailable to the host 
(Hanning and Diaz-Sanchez, 2015; Roto et al., 2015).   
The differences in results observed in DGGE when compared to NGS are potentially due 
to 1) heterologous sequences migrating to similar distances presenting banding patterns that 
would falsely allude to these sequences being phylogenetically related (Gafan and Spratt, 2005), 
2) limited gel capacity thereby mandating the pooling of samples for large sample sizes 
(McCartney, 2002), 3) pooled samples for DGGE therefore potentially increasing background 
noise present due to many more samples being analyzed, 4) various PCR conditions have been 
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observed to inaccurately reflect the presence and abundance of certain taxa (Chandler et al., 
1997), and 5) the hypervariable regions amplified in the current study for DGGE and NGS were 
V3 and V4 respectively. The hypervariable regions of the 16S rRNA gene chosen for 
amplification can greatly influence both the DGGE and NGS diversity profiles produced (Yu and 
Morrison, 2004; Chakravorty et al., 2007). The V3 region is typically used to identify taxa at the 
genus level, each band theorectically representing a unique genera of bacteria (Ercolini et al., 
2001; Hanning and Ricke, 2011). Furthermore, there is a degree of underestimation of taxonomic 
richness and classification of lower accuracy when only partial sequences are used as compared 
to full or near full-length sequences (Yarza et al., 2014). Therefore, it would be beneficial to 
compare the data collected in the current study with full-length 16S rRNA gene sequences from 
a mature and healthy poultry cecal microbiota.  
CONCLUSION 
The exact mechanism of XPC is not yet defined and the current research does not support 
or refute the hypothesis of modulation of the GIT microbiome. In comparing the results from 
both methods of DGGE and NGS, the DGGE methodology appeared to indicate a potential 
modulation of the cecal microbial populations caused by the various treatments utilized in this 
research. This same observation became less apparent in the NGS analysis of the cecal 
microbiota in that the analysis indicated minimal detectable alteration among the treatments. 
However, DGGE and NGS both revealed age of bird to have the greatest influence in the 
alteration of the cecal microbiota. Similarly, the temporal changes in the analysis of the cecal 
bacterial populations have been indicated as influential factors on the modulation of the cecal 
microbiome in previous studies at 7, 21, and 42 days post hatch (Oakley et al., 2014). Lastly, the 
cecal microbiota analysis only allows for the identification of who is present but does not reveal 
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the corresponding metabolic activity associated with these microorganisms. Further research is 
necessary to evaluate the mechanism of how XPC effects growth performance, pathogen 
invasion, and overall health. 
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Table 3 .1: Experimental design describing the levels of Original XPCTM per diet (starter, 
grower, finisher) contained in each treatment. 
                           Original XPCTM (g/kg) 
ID Description Starter (0- 16 d) Grower (16- 28 d) Finisher (28- 42 d) 
T1 Cocci-vaccine1 (no XPC) --- --- --- 
T2 Cocci-vaccine1 + XPC2 1.25 1.25 0.625 
T3 Cocci-vaccine1 + SAL3 (no XPC) --- --- --- 
T4 Cocci-vaccine1 + SAL3 + XPC2 1.25 1.25 0.625 
1. Coccivac-B (Merck, Kenilworth, NJ) sprayed at hatchery at 0 d. 
2. Diamond V Original XPCTM, Diamond V, Cedar Rapids, IA 
3. Salinomycin sodium included only in grower diet (16-28 d) at 0.044 g/kg, Sacox, 
Huvepharma, St. Louis, MO 
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Figure 3 .1A to C: Pooled samples in DGGE and phylogenetic trees from A) 16 d, B) 28 d, and 
C) 42 d sampling ages including T1 to T4: DGGE (left) and phylogenetic tree (right). Lanes 1 to 
4: T1 (Control) samples, lanes 5 to 8; T2 (XPC) samples, lanes 9 to 12: T3 (SAL) samples, and 
lanes 13 to 16: T4 (XPC + SAL) samples. Lanes from DGGE correspond to numbers labeled on 
the right side vertical axis of the phylogenetic tree.  
A) 
 
B) 
        
C) 
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Figure 3 .2A to D: Phylum level abundance analysis among age sampling points for each 
treatment: A) Control, B) Salinomycin, C) XPC, D) XPC + Salinomycin. Treatment inclusion of 
Salinomycin occurred in the grower diet (16 to 28 d). Therefore there is only analysis of 
treatments containing Salinomycin at 28 and 42 d, while treatments containing XPC at all three 
sampling age points: 16, 28, and 42 d. Differing letters indicate significant difference (P < 0.05). 
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Figure 3 .3A to D: Order level abundance analysis among age sampling points for each 
treatment: A) Control, B) Salinomycin, C) XPC, D) XPC + Salinomycin. Treatment inclusion of 
Salinomycin occurred in the grower diet (16 to 28 d). Therefore there is only analysis of 
treatments containing Salinomycin at 28 and 42 d, while treatments containing XPC at all three 
sampling age points: 16, 28, and 42 d. Differing letters indicate significant difference (P < 0.05). 
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Figure 3 .4: Genus level bar chart generated from QIIME analysis separated by sampling age. 
Colored font corresponds to genera abundance. 
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Figure 3 .5: Species level abundance analysis among age sampling points for each treatment 
Treatment inclusion of Salinomycin occurred in the grower diet (16 to 28 d). Therefore there is 
only analysis of treatments containing Salinomycin at 28 and 42 d, while treatments containing 
XPC at all three sampling ages: 16, 28, and 42 d (graphs identified as “Salinomycin” and XPC + 
Salinomycin” are identical to “Control” and “XPC” at 16 days, respectively). 
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Figure 3 6A and B: Rarefaction curves for A) Chao1 indices and B) OTUs determined at the 
species level among all sampling age points (16, 28, 42 days). Statements of statistical 
significance are based on P < 0.05. 
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Figure 3 .7A and B: Mean Shannon diversity index determined at the species level comparing 
A) sampling age (16, 28, 42 days) and B) treatments (Control, Salinomycin, XPC, XPC + 
Salinomycin). Each marker indicates the mean Shannon diversity index; brackets represent the 
Mean ± SEM. Astericks (*) indicates a significant difference (P < 0.05). 
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Figure 3 .8A and B: UniFrac PCoA plots A) unweighted and B) weighted plots of individual 
birds among sampling ages. Each colored dot is representative of a different sampling age. 
Statements of statistical significance are based on P < 0.05. 
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Conclusion 
 This thesis was focused on Original-XPCTM (XPC), a product containing a mixture of 
fermentation metabolites. The objectives of this research were to observe the effects on 
Salmonella survival and the modulation of the intestinal microbiome using both an in vitro assay 
and an in vivo feeding trial. The results from chapter two (the in vitro assay) revealed XPC to 
allow for an accelerated rate at which S. Typhimurium survival is reduced within the cecal 
contents, regardless of variation among the microbial populations observed among the two trials 
presented (the variation observed among the trials is speculated to be due to environmental 
factors). In chapter three (the in vivo feeding trial), supplementation with XPC indicated 
phylogenetic differences via denaturing gradient gel electrophoresis (DGGE) associated with 
both the treatments and sampling ages, while the Illumina MiSeq sequencing results revealed 
significant differences only corresponding to sampling age. The analysis of the methods between 
the Illumina MiSeq and the DGGE indicated that although both characterize the microbial 
populations to different extents, the two methods have factors that limit the degree to which these 
methods are able to be directly compared (V3 vs. V4, pooled vs. individual samples, presence of 
background noise). In both chapters, treatment with XPC indicated little detectable influence on 
the intestinal microbiota, yet revealed the maturity of the cecal microbiome to increase the 
species diversity and richness, often associated with a healthy host. Lastly, this research 
illustrated the reliability of the in vitro assay utilized in the current research, as the in vivo 
feeding trial results were similar to the in vitro assay results. 
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